
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A4500003C993D48A7B1.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="cancers" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10452460/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452460/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Cancers" /><meta name="citation_title" content="In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia" /><meta name="citation_author" content="Joelle C. Boulos" /><meta name="citation_author_institution" content="Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany; ed.zniam-inu@soluoboj" /><meta name="citation_author" content="Manik Chatterjee" /><meta name="citation_author_institution" content="Translational Oncology, Comprehensive Cancer Center Mainfranken, University Hospital W&#x000fc;rzburg, 97080 W&#x000fc;rzburg, Germany; ed.wku@m_eejrettahc" /><meta name="citation_author" content="Letian Shan" /><meta name="citation_author_institution" content="The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310053, China; moc.liamxof@nahs.naitel" /><meta name="citation_author" content="Thomas Efferth" /><meta name="citation_author_institution" content="Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany; ed.zniam-inu@soluoboj" /><meta name="citation_publication_date" content="2023/08" /><meta name="citation_issue" content="16" /><meta name="citation_volume" content="15" /><meta name="citation_doi" content="10.3390/cancers15164136" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10452460/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10452460/" /><meta name="citation_pmid" content="37627164" /><meta name="DC.Title" content="In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Multidisciplinary Digital Publishing Institute  (MDPI)" /><meta name="DC.Contributor" content="Joelle C. Boulos" /><meta name="DC.Contributor" content="Manik Chatterjee" /><meta name="DC.Contributor" content="Letian Shan" /><meta name="DC.Contributor" content="Thomas Efferth" /><meta name="DC.Date" content="2023 Aug" /><meta name="DC.Identifier" content="10.3390/cancers15164136" /><meta name="DC.Language" content="en" /><meta property="og:title" content="In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia" /><meta property="og:type" content="article" /><meta property="og:description" content="Hematological neoplasms afflict millions of children and adults yearly and are often uncurable due to refractory illness and recurrence. Therefore, new treatment approaches are required. The proto-oncogene c-MYC has been linked to carcinogenesis, particularly ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452460/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10452460/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Cancers%20(Basel)%22[journal]" class="navlink">Cancers (Basel)</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10452460
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10452460/pdf/cancers-15-04136.pdf" class="int-view">PDF (5.2M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10452460/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10452460/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10452460" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10452460%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="ROHc3cuMhVHLBEpNtgPDB2lqFESaVTGoZnVQ2qyhxlHT1FiXvzaLoLbPowIOuc3c">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10452460%2F&amp;text=In%20Silico%2C%20In%20Vitro%2C%20and%20In%20Vivo%20Investigations%20on%20Adapalene%20as%20Repurposed%20Third%20Generation%20Retinoid%20against%20Multiple%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10452460%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452460/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10452460/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37627164/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10452460/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37627164/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10452460/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10452460/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Cancers%20(Basel)%22[journal]" class="navlink">Cancers (Basel)</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10452460
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-cancers.png" alt="Logo of cancers" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.mdpi.com/journal/cancers" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Cancers (Basel).</span> 2023 Aug; 15(16): 4136. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Aug 16. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.3390%2Fcancers15164136" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3390/cancers15164136</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10452460</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37627164">37627164</a></div></div></div><h1 class="content-title">In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Boulos%20JC%5BAuthor%5D" class="affpopup" co-rid="_co_idm140620226303984" co-class="co-affbox">Joelle C. Boulos</a>, <span class="fm-role">Conceptualization</span>, <span class="fm-role">Methodology</span>, <span class="fm-role">Software</span>, <span class="fm-role">Validation</span>, <span class="fm-role">Formal analysis</span>, <span class="fm-role">Investigation</span>, <span class="fm-role">Data curation</span>, <span class="fm-role">Writing &#x02013; original draft</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>, <span class="fm-role">Visualization</span>, <span class="fm-role">Project administration</span>, <span class="fm-role">Funding acquisition</span>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chatterjee%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140620230890928" co-class="co-affbox">Manik Chatterjee</a>, <span class="fm-role">Resources</span>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shan%20L%5BAuthor%5D" class="affpopup" co-rid="_co_idm140620233271920" co-class="co-affbox">Letian Shan</a>, <span class="fm-role">Validation</span>,<sup>3</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Efferth%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140620233268720" co-class="co-affbox">Thomas Efferth</a>, <span class="fm-role">Conceptualization</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>, <span class="fm-role">Supervision</span><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140620226303984"><h3 class="no_margin">Joelle C. Boulos</h3><p><sup>1</sup>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany; <a href="mailto:dev@null" data-email="ed.zniam-inu@soluoboj" class="oemail">ed.zniam-inu@soluoboj</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Boulos%20JC%5BAuthor%5D">Joelle C. Boulos</a></div></div><div id="_co_idm140620230890928"><h3 class="no_margin">Manik Chatterjee</h3><p><sup>2</sup>Translational Oncology, Comprehensive Cancer Center Mainfranken, University Hospital W&#x000fc;rzburg, 97080 W&#x000fc;rzburg, Germany; <a href="mailto:dev@null" data-email="ed.wku@m_eejrettahc" class="oemail">ed.wku@m_eejrettahc</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chatterjee%20M%5BAuthor%5D">Manik Chatterjee</a></div></div><div id="_co_idm140620233271920"><h3 class="no_margin">Letian Shan</h3><p><sup>3</sup>The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310053, China; <a href="mailto:dev@null" data-email="moc.liamxof@nahs.naitel" class="oemail">moc.liamxof@nahs.naitel</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shan%20L%5BAuthor%5D">Letian Shan</a></div></div><div id="_co_idm140620233268720"><h3 class="no_margin">Thomas Efferth</h3><p><sup>1</sup>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany; <a href="mailto:dev@null" data-email="ed.zniam-inu@soluoboj" class="oemail">ed.zniam-inu@soluoboj</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Efferth%20T%5BAuthor%5D">Thomas Efferth</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Anupam Bishayee, <span class="fm-role">Academic Editor</span> and  Rajeev K. Singla, <span class="fm-role">Academic Editor</span></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140620224224592_ai idm140620226304112_ai idm140620221680080_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140620224224592_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140620224224592_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140620224224592_ai" style="display:none"><div class="fm-affl" id="af1-cancers-15-04136"><sup>1</sup>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany; <a href="mailto:dev@null" data-email="ed.zniam-inu@soluoboj" class="oemail">ed.zniam-inu@soluoboj</a></div><div class="fm-affl" id="af2-cancers-15-04136"><sup>2</sup>Translational Oncology, Comprehensive Cancer Center Mainfranken, University Hospital W&#x000fc;rzburg, 97080 W&#x000fc;rzburg, Germany; <a href="mailto:dev@null" data-email="ed.wku@m_eejrettahc" class="oemail">ed.wku@m_eejrettahc</a></div><div class="fm-affl" id="af3-cancers-15-04136"><sup>3</sup>The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310053, China; <a href="mailto:dev@null" data-email="moc.liamxof@nahs.naitel" class="oemail">moc.liamxof@nahs.naitel</a></div><div id="c1-cancers-15-04136"><sup>*</sup>Correspondence: <a href="mailto:dev@null" data-email="ed.zniam-inu@htreffe" class="oemail">ed.zniam-inu@htreffe</a>; Tel./Fax: +49-6131-3925751</div></div><div class="fm-article-notes hide half_rhythm" id="idm140620224224592_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Jun 28; Revised 2023 Aug 9; Accepted 2023 Aug 13.</div></div><div class="permissions half_rhythm hide" id="idm140620224224592_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 by the authors.</div><div class="license half_rhythm">Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">https://creativecommons.org/licenses/by/4.0/</a>).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div><a href="/pmc/articles/PMC10452460/bin/cancers-15-04136-s001.zip" data-ga-action="click_feat_suppl">cancers-15-04136-s001.zip</a><span style="color:gray"> (424K)</span></div><div class="small guid">GUID: B1A0BE83-99D8-4708-B146-31F3357391CD</div></div></dd></dl><dl data-length="140" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy.</p></dd></dl></div><div id="abstract-a.q.b.r" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.q.b.rtitle">Abstract</h2><!--article-meta--><div><div id="sec-a.q.b.r.a" class="sec sec-first"><h3 id="sec-a.q.b.r.atitle">Simple Summary</h3><p class="p p-first-last">Hematological neoplasms afflict millions of children and adults yearly and are often uncurable due to refractory illness and recurrence. Therefore, new treatment approaches are required. The proto-oncogene c-MYC has been linked to carcinogenesis, particularly in hematological malignancies. Consequently, to develop new and effective therapies for blood cancers, it is essential to target c-MYC, specifically that c-MYC inhibitors have not yet received clinical approval. In this research, the verification of adapalene as a c-MYC inhibitor may be a glimmer of hope, especially that it is an already Food and Drug Administration (FDA)-approved drug, and its toxicity profiles, pharmacokinetics, and pharmacodynamics are well established. Our study presents a rationale that the discovery of adapalene as a c-MYC inhibitor may significantly lower the drug development costs of new anticancer medications. It also provides further insights in the future of adapalene-based designs that could result in more effective and targeted innovative therapies for multiple myeloma.</p></div><div id="sec-a.q.b.r.b" class="sec sec-last"><h3 id="sec-a.q.b.r.btitle">Abstract</h3><p class="p p-first-last">The majority of hematopoietic cancers in adults are incurable and exhibit unpredictable remitting-relapsing patterns in response to various therapies. The proto-oncogene c-MYC has been associated with tumorigenesis, especially in hematological neoplasms. Therefore, targeting c-MYC is crucial to find effective, novel treatments for blood malignancies. To date, there are no clinically approved c-MYC inhibitors. In this study, we virtually screened 1578 Food and Drug Administration (FDA)-approved drugs from the ZINC15 database against c-MYC. The top 117 compounds from PyRx-based screening with the best binding affinities to c-MYC were subjected to molecular docking studies with AutoDock 4.2.6. Retinoids consist of synthetic and natural vitamin A derivatives. All-trans-retinoic acid (ATRA) were highly effective in hematological malignancies. In this study, adapalene, a third-generation retinoid usually used to treat acne vulgaris, was selected as a potent c-MYC inhibitor as it robustly bound to c-MYC with a lowest binding energy (LBE) of &#x02212;7.27 kcal/mol, a predicted inhibition constant (pKi) of 4.69 &#x000b5;M, and a dissociation constant (K<sub>d</sub> value) of 3.05 &#x000b5;M. Thus, we examined its impact on multiple myeloma (MM) cells in vitro and evaluated its efficiency in vivo using a xenograft tumor zebrafish model. We demonstrated that adapalene exerted substantial cytotoxicity against a panel of nine MM and two leukemic cell lines, with AMO1 cells being the most susceptible one (IC<sub>50</sub> = 1.76 &#x000b1; 0.39 &#x000b5;M) and, hence, the focus of this work. Adapalene (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, 2 &#x000d7; IC<sub>50</sub>) decreased c-MYC expression and transcriptional activity in AMO1 cells in a dose-dependent manner. An examination of the cell cycle revealed that adapalene halted the cells in the G<sub>2</sub>/M phase and increased the portion of cells in the sub-G<sub>0</sub>/G<sub>1</sub> phase after 48 and 72 h, indicating that cells failed to initiate mitosis, and consequently, cell death was triggered. Adapalene also increased the number of p-H3(Ser10) positive AMO1 cells, which is a further proof of its ability to prevent mitotic exit. Confocal imaging demonstrated that adapalene destroyed the tubulin network of U2OS cells stably transfected with a cDNA coding for &#x003b1;-tubulin-GFP, refraining the migration of malignant cells. Furthermore, adapalene induced DNA damage in AMO1 cells. It also induced apoptosis and autophagy, as demonstrated by flow cytometry and western blotting. Finally, adapalene impeded tumor growth in a xenograft tumor zebrafish model. In summary, the discovery of the vitamin A derivative adapalene as a c-MYC inhibitor reveals its potential as an avant-garde treatment for MM.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">drug repurposing, hematological malignancies, microtubules, programmed cell death, targeted chemotherapy, third-generation retinoid, xenograft tumor zebrafish model</span></div></div><div id="sec1-cancers-15-04136" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1-cancers-15-04136title">1. Introduction</h2><p class="p p-first">Cancers affecting lymph nodes, bone marrow, and blood are collectively known as hematological malignancies. This category comprises lymphoma (Hodgkin and non-Hodgkin types), multiple myeloma (MM), and different kinds of leukemia such as chronic myeloid (CML), acute myeloid (AML), chronic lymphocytic (CLL), and acute lymphocytic (ALL). All together, these hematopoietic neoplasms constitute about 9% of all cancers that are newly diagnosed, with lymphomas (particularly non-Hodgkin&#x02019;s) being more prevalent than MM or leukemia. Blood cancers often increase with age, with the exception of Hodgkin&#x02019;s lymphoma and ALL [<a href="#B1-cancers-15-04136" rid="B1-cancers-15-04136" class=" bibr popnode">1</a>].</p><p>MM is a rare blood malignancy that accounts for 1% of all cancers and 10% of hematological cancers. It is the second most frequent blood cancer in industrialized countries. A hallmark of MM is the invasion of the bone marrow by monoclonal plasma cells which produce and discharge monoclonal immunoglobulin into the blood and urine [<a href="#B2-cancers-15-04136" rid="B2-cancers-15-04136" class=" bibr popnode">2</a>]. The amassment of these immunoglobulins causes organ malfunction such as bone lesions, anemia, renal insufficiency, and hypercalcemia. At this point, patients begin to develop symptoms. MM generally starts as an asymptomatic precursor malignancy. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering undetermined significance (MGUS) are the diseases that manifest at this stage in which genetic defects, such as hyperdiploidy and the involvement of immunoglobulin heavy chain in translocations, are initiated [<a href="#B3-cancers-15-04136" rid="B3-cancers-15-04136" class=" bibr popnode">3</a>]. A translocation adjoining an oncogene next to an immunoglobulin enhancer occurs in the plasma cells of around half of individuals with MGUS [<a href="#B4-cancers-15-04136" rid="B4-cancers-15-04136" class=" bibr popnode">4</a>]. These translocations might serve as a starting point for later oncogenic processes that eventually engender MM. Malignant cell gene expression profiling revealed diverse disease subgroups, likely attributable to the activation of several oncogenic pathways in various patients [<a href="#B5-cancers-15-04136" rid="B5-cancers-15-04136" class=" bibr popnode">5</a>].</p><p>c-MYC deregulation may contribute to the progression of MGUS to MM [<a href="#B6-cancers-15-04136" rid="B6-cancers-15-04136" class=" bibr popnode">6</a>]. Several processes, including mutation, translocation, and gene amplification, result in c-MYC overexpression. Numerous MM cell lines and, to a certain extent, primary MM cells (15&#x02013;46%) harbor c-MYC chromosomal rearrangements [<a href="#B7-cancers-15-04136" rid="B7-cancers-15-04136" class=" bibr popnode">7</a>]. Additionally, 40% of all c-MYC translocations in human MM cells do not affect immunoglobulin genes. Contrarily, patients overexpressing c-MYC have been delineated in a greater portion than the ones with c-MYC translocations [<a href="#B8-cancers-15-04136" rid="B8-cancers-15-04136" class=" bibr popnode">8</a>]. Importantly, the experimental c-MYC knockdown was lethal to MM cells, implying that MM may be addicted for c-MYC activity to survive, and targeting c-MYC may improve the treatment outcome of MM [<a href="#B9-cancers-15-04136" rid="B9-cancers-15-04136" class=" bibr popnode">9</a>].</p><p>Even with recent medical advancements such as monoclonal antibodies, histone deacetylase inhibitors, immunomodulatory drugs, proteasome inhibitors, anthracyclines, alkylating agents, corticosteroids, stem cell transplantation, radiotherapy, bisphosphonate treatment, and combination therapies [<a href="#B10-cancers-15-04136" rid="B10-cancers-15-04136" class=" bibr popnode">10</a>], patients with MM frequently experience multiple relapses following one or more treatment procedures, or evolve into a refractory state, primarily as a result of drug resistance. Having in mind the impending negative effects of the available hematopoietic treatments and given that c-MYC dysregulation is a distinct feature in the genetic profile of MM, alternative approaches were forged to identify novel drugs targeting c-MYC, especially because such therapies are not yet available [<a href="#B11-cancers-15-04136" rid="B11-cancers-15-04136" class=" bibr popnode">11</a>,<a href="#B12-cancers-15-04136" rid="B12-cancers-15-04136" class=" bibr popnode">12</a>]. To date, numerous approaches have been developed to specifically target c-MYC in MM. Nevertheless, the pharmacokinetic characteristics and the efficacy of many of these strategies are subpar. Moreover, finding ligands that directly inhibit c-MYC is still challenging [<a href="#B13-cancers-15-04136" rid="B13-cancers-15-04136" class=" bibr popnode">13</a>].</p><p>Despite improvements in technology and the advanced perception of human diseases, the development of new therapeutic approaches has proceeded far slower than anticipated. Drug repurposing, often referred to as drug reprofiling, repositioning, or re-tasking, could be an alternate method for discovering new applications for approved or experimental drugs that go beyond the limits of the typical medical prescription [<a href="#B14-cancers-15-04136" rid="B14-cancers-15-04136" class=" bibr popnode">14</a>]. This strategy has significant advantages over developing a brand-new medication for a specific indication because the toxicity profiles, pharmacokinetics, and pharmacodynamics of commercially available drugs are well established. If repurposing is successful, it is possible to significantly save time and financial outlays on a drug&#x02019;s preclinical and clinical testing [<a href="#B15-cancers-15-04136" rid="B15-cancers-15-04136" class=" bibr popnode">15</a>].</p><p>Adapalene (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001" co-legend-rid="lgnd_cancers-15-04136-f001"><span>Figure 1</span></a>A), also known as CD271 and differin, belongs to the third generation of retinoids that were approved by the Food and Drug Administration (FDA) in 1996 to treat acne vulgaris [<a href="#B16-cancers-15-04136" rid="B16-cancers-15-04136" class=" bibr popnode">16</a>]. Adapalene is a naphthoic acid derivative known to bind to retinoic acid nuclear receptors [<a href="#B17-cancers-15-04136" rid="B17-cancers-15-04136" class=" bibr popnode">17</a>]. There are several documented actions of adapalene, including immunomodulatory, anti-proliferative, anti-inflammatory, comedolytic, anti-bacterial, and neuroprotective activities [<a href="#B18-cancers-15-04136" rid="B18-cancers-15-04136" class=" bibr popnode">18</a>]. Regarding anticancer studies, adapalene promoted G1 cell cycle arrest and inhibited CDK2 in colorectal cancer cells. It also prompted apoptotic cell death in hepatoma cells by modulating the ratio of Bax and Bcl-2 [<a href="#B17-cancers-15-04136" rid="B17-cancers-15-04136" class=" bibr popnode">17</a>,<a href="#B19-cancers-15-04136" rid="B19-cancers-15-04136" class=" bibr popnode">19</a>]. Furthermore, adapalene inhibited the proliferation of melanoma cells through S-phase arrest of the cell cycle, and subsequently induced apoptosis through DNA damage [<a href="#B20-cancers-15-04136" rid="B20-cancers-15-04136" class=" bibr popnode">20</a>]. Adapalene suppressed the proliferation of ES-2 ovarian cancer cells by inhibiting glutamicoxaloacetic transaminase 1 (GOT1) [<a href="#B21-cancers-15-04136" rid="B21-cancers-15-04136" class=" bibr popnode">21</a>]. It also reduced the growth of prostate cancer cells by triggering DNA damage, halting the cell cycle in the S phase, and evoking apoptosis [<a href="#B22-cancers-15-04136" rid="B22-cancers-15-04136" class=" bibr popnode">22</a>]. Finally, adapalene arrested triple-negative breast cancer cells in the S-phase, inhibiting their proliferation [<a href="#B23-cancers-15-04136" rid="B23-cancers-15-04136" class=" bibr popnode">23</a>]. All these findings proved that repurposing adapalene for cancer treatment represents a promising approach.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f001" co-legend-rid="lgnd_cancers-15-04136-f001"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620269040960"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620269040960"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f001"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001">Figure 1</a></div><!--caption a7--><div class="caption"><p>Molecular docking of candidate c-MYC inhibitors. (<strong>A</strong>) Chemical structure of adapalene. (<strong>B</strong>) Pie chart showing the percentage of FDA-approved ligands belonging to a particular lowest binding energy (kcal/mol) range. (<strong>C</strong>) Correlation coefficient representation of predicted inhibition constant (pKi) vs. lowest binding energies (LBE). (<strong>D</strong>) 2D representations of the various interactions between the amino acid residues of c-MYC and the corresponding compounds (10058-F4, 10074-G5, atovaquone, and adapalene) were generated using Discovery Studio Visualizer software (version v.21.1.0.20298). The lowest binding energies (LBE) and the predicted inhibition constant (Ki) of each compound were acquired from AutoDockTools 4.2.6.</p></div></div></div><p class="p p-last">The aim of the present study is to locate prospective FDA-approved drugs that target the oncogenic transcription factor c-MYC using in silico tools (virtual screening by PyRx and molecular docking by AutoDock) to examine the molecular interaction of the preeminent FDA-approved drug adapalene and c-MYC using microscale thermophoresis (MST), and to confirm that adapalene is an effective c-MYC inhibitor by a MYC reporter assay. Given that MM cells depend on c-MYC for their survival, and since there are currently no reports on the application of adapalene for the treatment of hematological malignancies, we were further interested in investigating the effect of adapalene against a panel of MM cell lines, determining its mechanism of action and its cell death modality through in vitro studies. Finally, we verified its growth inhibitory efficacy in vivo using a T-ALL zebrafish model.</p></div><div id="sec2-cancers-15-04136" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2-cancers-15-04136title">2. Materials and Methods</h2><div id="sec2dot1-cancers-15-04136" class="sec sec-first"><h3 id="sec2dot1-cancers-15-04136title">2.1. Virtual Drug Screening and Molecular Docking Analyses</h3><p class="p p-first">The FDA-approved drug library, consisting of 1577 compounds, was downloaded from the Zinc15 database (<a href="https://zinc15.docking.org/">https://zinc15.docking.org/</a>, accessed on 25 April 2019) to evaluate the in silico binding strength of those compounds toward c-MYC using PyRx0.9 virtual screening tool and AutoDock 4.2.6 molecular docking.</p><p>The 3D structures of the ligands were downloaded as standard data files (sdf). The crystal structure of c-MYC was downloaded from the Protein Data Bank (<a href="http://www.rcsb.org/">http://www.rcsb.org/</a>, accessed on 25 April 2019) as a PDB file (PDB ID: 1NKP) [<a href="#B24-cancers-15-04136" rid="B24-cancers-15-04136" class=" bibr popnode">24</a>]. Using AutoDockTool 1.5.6 (The Scripps Research Institute, La Jolla, CA, USA), the protein crystal structure was subsequently improved by removing water molecules and by adding missing hydrogen atoms. Following that, the PDB file was converted to Protein Data Bank Partial Charge and Atom Type (PDBQT) file [<a href="#B25-cancers-15-04136" rid="B25-cancers-15-04136" class=" bibr popnode">25</a>]. Prior to PyRx running, the energy of the FDA-approved ligands was minimized, and the files were converted to PDBQT. The ligands were then sorted according to their lowest binding energy (kcal/mol), which was obtained by the PyRx virtual screening tool.</p><p class="p p-last">The top 170 compounds with the lowest binding energy were selected for further molecular docking analysis using AutoDock 4.2.6 (Center for Computational Structural Biology ccsb, La Jolla, CA, USA) [<a href="#B25-cancers-15-04136" rid="B25-cancers-15-04136" class=" bibr popnode">25</a>]. Two known c-MYC inhibitors, 10058-F4 and 10074-G5, were used as positive controls [<a href="#B26-cancers-15-04136" rid="B26-cancers-15-04136" class=" bibr popnode">26</a>,<a href="#B27-cancers-15-04136" rid="B27-cancers-15-04136" class=" bibr popnode">27</a>]. The grid box was set to mask the whole protein with the center of the grid box at x = 65.333, y = 62.507, and z = 42.943 with the number of grid points (npts) of 54 in x, 108 in y, and 70 in z. The calculations were performed using a Lamarckian algorithm provided by AutoDock with 250 runs and 2,500,000 energy evaluation. The AutoDock RMSD cluster analysis generated the expected results as DLG files. Interacting with amino acids and visualizations was performed with BIOVIA Discovery Studio Visualizer (<a href="https://discover.3ds.com/">https://discover.3ds.com/</a>, accessed on 20 May 2019).</p></div><div id="sec2dot2-cancers-15-04136" class="sec"><h3 id="sec2dot2-cancers-15-04136title">2.2. Microscale Thermophoresis</h3><p class="p p-first-last">MST was performed to study the in vitro binding of adapalene to recombinant human c-MYC protein (ab169901, Abcam, Cambridge, UK) [<a href="#B28-cancers-15-04136" rid="B28-cancers-15-04136" class=" bibr popnode">28</a>]. Briefly, the Protein Labeling Kit Blue-NHS (L003, NanoTemper Technologies GmbH, Munich, Germany) was used to fluorescently tag the c-MYC protein following the manufacturer&#x02019;s instructions. With a final c-MYC concentration of 200 nM, MST was performed at 50% LED intensity and 40% MST power. Finally, the fit curve and the dissociation constant (K<sub>d</sub>) of adapalene were generated with the NanoTemper Analysis Software version 2.2.4.</p></div><div id="sec2dot3-cancers-15-04136" class="sec"><h3 id="sec2dot3-cancers-15-04136title">2.3. MYC Cignal Reporter Assay</h3><p class="p p-first-last">The Qiagen cignal MYC reporter assay kit (CCS-012L, Germantown, MD, USA) was used to examine the impact of adapalene on c-MYC activity, as previously described [<a href="#B29-cancers-15-04136" rid="B29-cancers-15-04136" class=" bibr popnode">29</a>]. Briefly stated, HEK293 human embryonic kidney cells were transfected with a c-MYC-luciferase reporter construct and grown in accordance with the instructions provided by the manufacturer. Cells were then exposed to adapalene (5 and 10 &#x000b5;M), DMSO as negative control, or 10058-F4 (127.5 2 &#x000b5;M) as positive control. After 24 h, the Dual-glo<sup>&#x000ae;</sup> Luciferase Reporter Assay System (E2920, Promega, Madison, WI, USA) was added to each well to quantify the activity of the c-MYC promoter by measuring the luminescence of firefly and renilla luciferases using an Infinite M2000 Pro<sup>TM</sup> plate reader (Tecan, Crailsheim, Germany).
</p><div class="disp-formula" id="FD1-cancers-15-04136"><div class="f"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="mm1" display="block" overflow="scroll"><mrow><mrow><mi mathvariant="normal">c</mi><mo>&#x02212;</mo><mi mathvariant="normal">M</mi><mi mathvariant="normal">y</mi><mi mathvariant="normal">c</mi><mo>&#x000a0;</mo><mi mathvariant="normal">a</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">t</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">v</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">t</mi><mi mathvariant="normal">y</mi><mo>=</mo><mfrac><mrow><mi mathvariant="normal">f</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">y</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">m</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">e</mi></mrow><mrow><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">a</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">m</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">e</mi></mrow></mfrac></mrow></mrow></math></div></div><p>
</p><div class="disp-formula" id="FD2-cancers-15-04136"><div class="f"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="mm2" display="block" overflow="scroll"><mrow><mrow><mi mathvariant="normal">R</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">t</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">v</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">e</mi><mo>=</mo><mn>100</mn><mo>&#x000d7;</mo><mfenced separators="|"><mrow><mfrac><mrow><mi mathvariant="normal">f</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">y</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">m</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">e</mi></mrow><mrow><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">a</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">m</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">e</mi></mrow></mfrac></mrow></mfenced></mrow></mrow></math></div></div><p>
</p><div class="disp-formula" id="FD3-cancers-15-04136"><div class="f"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="mm3" display="block" overflow="scroll"><mrow><mrow><mi mathvariant="normal">N</mi><mi mathvariant="normal">o</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">m</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">z</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">d</mi><mo>&#x000a0;</mo><mi mathvariant="normal">c</mi><mo>&#x02212;</mo><mi mathvariant="normal">M</mi><mi mathvariant="normal">y</mi><mi mathvariant="normal">c</mi><mo>&#x000a0;</mo><mi mathvariant="normal">a</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">t</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">v</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">t</mi><mi mathvariant="normal">y</mi><mo>=</mo><mfrac><mrow><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">t</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">v</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mo>(</mo><mi mathvariant="normal">s</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">m</mi><mi mathvariant="normal">p</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">e</mi><mo>)</mo></mrow><mrow><mi mathvariant="normal">r</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">t</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">v</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mi mathvariant="normal">l</mi><mi mathvariant="normal">u</mi><mi mathvariant="normal">c</mi><mi mathvariant="normal">i</mi><mi mathvariant="normal">f</mi><mi mathvariant="normal">e</mi><mi mathvariant="normal">r</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">s</mi><mi mathvariant="normal">e</mi><mo>&#x000a0;</mo><mo>(</mo><mi mathvariant="normal">D</mi><mi mathvariant="normal">M</mi><mi mathvariant="normal">S</mi><mi mathvariant="normal">O</mi><mo>)</mo></mrow></mfrac></mrow></mrow></math></div></div><p></p></div><div id="sec2dot4-cancers-15-04136" class="sec"><h3 id="sec2dot4-cancers-15-04136title">2.4. Cell Lines</h3><p class="p p-first">Leukemia cells, including the drug-sensitive CCRF-CEM T-cell acute lymphoblastic leukemia (T-ALL) and their multidrug-resistant P-glycoprotein-overexpressing CEM/ADR5000 subline, were provided by Dr. Axel Sauerbrey (Children&#x02019;s Hospital, University of Jena, Jena, Germany). HL60 and U266 were provided by Prof. Markus Munder (University Medical Center of the Johannes Gutenberg University, Mainz, Germany). MM cells, including AMO1, KMS12BM, MolP8, NCI-H929, OPM2, KMS11, L363, and JJN3, were kindly supplied by Dr. Manik Chatterjee (University of W&#x000fc;rzburg, W&#x000fc;rzburg, Germany). RPMI8226 cells were obtained from the American Type Cell Culture Collection (ATCC<sup>&#x000ae;</sup> CCL-155&#x02122;, ATCC, Manassas, VA, USA).</p><p>Leukemia cells and MM were maintained in RPMI 1640 (Life Technologies, Darmstadt, Germany), supplemented with 10% FBS (Life Technologies) and 1% penicillin (1000 U/mL)/streptomycin (100 &#x003bc;g/mL) (Life Technologies). Cells were incubated in a 5% CO<sub>2</sub>/37 &#x000b0;C incubator.</p><p>HEK293 were kindly provided by Prof. Dr. Christina Friedland (Johannes Gutenberg University, Mainz, Germany). Human bone osteosarcoma cells (U2OS) that persistently express an &#x003b1;-tubulin-GFP construct were kindly provided by Dr. Joachim Hehl (Light microscope center, ETH Zurich, Zurich, Switzerland). HEK293 and U2OS were maintained in DMEM (Life Technologies), supplemented with 10% FBS (Life Technologies) and 1% penicillin (1000 U/mL)/streptomycin (100 &#x003bc;g/mL) (Life Technologies). Cells were incubated in a 5% CO<sub>2</sub>/37 &#x000b0;C incubator.</p><p>Fresh blood samples were obtained from a healthy individual and placed in plastic Monovette EDTA tubes at the Department of Hematology, Oncology, and Pneumology (University Medical Center of the Johannes Gutenberg University, Mainz, Germany).</p><p class="p p-last">Histopaque<sup>&#x000ae;</sup> (Sigma-Aldrich, Taufkirchen, Germany) was used to collect human peripheral blood mononuclear cells (PBMCs). In a few words, 3 mL of fresh blood was cautiously deposited on top of Histopaque<sup>&#x000ae;</sup> and centrifuged at 400&#x000d7; <em>g</em>/4 &#x000b0;C for 30 min. The buffy coat made up of PBMCs was then isolated, rinsed with PBS, and centrifuged three times at 250 &#x000d7; <em>g</em>, for 10 min each. The resulting cell pellet was cultured in Panserin 413 growth media (PAN-Biotech, Aidenbach, Germany) and supplemented with 2% phytohemagglutinin M (PHA-M, Life Technologies).</p></div><div id="sec2dot5-cancers-15-04136" class="sec"><h3 id="sec2dot5-cancers-15-04136title">2.5. Cell Viability Assessment</h3><p class="p p-first-last">The sensitivity of MM cells, leukemia cells, and PBMCs to adapalene was evaluated by the resazurin reduction assay, as previously described [<a href="#B30-cancers-15-04136" rid="B30-cancers-15-04136" class=" bibr popnode">30</a>]. In brief, 10<sup>4</sup> cells were seeded in each well of a flat bottom 96-well plate. Cells were directly treated with 10 different concentrations of adapalene (Activate Scientific, Prien am Chiemsee, Bavaria) which are 3-fold apart from one another, ranging from 100 &#x000b5;M to 0.003 &#x000b5;M for MM and T-ALL cells. However, when 10-fold apart from one another, they ranged from 100 &#x000b5;M to 10<sup>&#x02212;7</sup> &#x000b5;M for PBMCs. The plates were incubated for 72 h at 5% CO<sub>2</sub>/37 &#x000b0;C and then re-incubated for another 4 h under the same conditions, with 20 &#x003bc;L of resazurin (0.01% <em>w</em>/<em>v</em>; Sigma-Aldrich) added to each well. An Infinite M2000 Pro plate reader (Tecan, Crailsheim, Germany) was used to measure resorufin fluorescence, produced by the reduction of resazurin by live cells, at 544&#x02013;590 nm (excitation-emission wavelengths). Afterward, cell viability was plotted vs. adapalene concentration, and the IC<sub>50</sub> values from three separate experiments with six repeats each were calculated with GraphPad Prism 5 software (GraphPad Software, San Diego, CA, USA).</p></div><div id="sec2dot6-cancers-15-04136" class="sec"><h3 id="sec2dot6-cancers-15-04136title">2.6. Cell Cycle Analysis</h3><p class="p p-first-last">The cell cycle progression of AMO1 cells incubated with different adapalene concentrations (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, or 2 &#x000d7; IC<sub>50</sub>) or media for 48 and 72 h was examined by propidium iodide (PI) staining (Thermo Fisher Scientific, Dreieich, Germany). Cells were collected and maintained at &#x02212;20 &#x000b0;C in 80% ethanol. Following the corresponding incubation time, cells were kept in PI staining solution at 4 &#x000b0;C for 15 min. Later on, the amount of PI staining was assessed with an Accouri C6 flow cytometer (Becton-Dickinson, Heidelberg, Germany). Total DNA content was calculated on FL2-A [<a href="#B31-cancers-15-04136" rid="B31-cancers-15-04136" class=" bibr popnode">31</a>,<a href="#B32-cancers-15-04136" rid="B32-cancers-15-04136" class=" bibr popnode">32</a>].</p></div><div id="sec2dot7-cancers-15-04136" class="sec"><h3 id="sec2dot7-cancers-15-04136title">2.7. Confocal Microscopy of p-H3(Ser10)</h3><p class="p p-first-last">AMO1 cells were incubated with adapalene (1 &#x000d7; IC<sub>50</sub> or 2 &#x000d7; IC<sub>50</sub>) or DMSO at 5% CO<sub>2</sub>/37 &#x000b0;C for 48 h. Afterwards, cells were harvested, washed with PBS, and cytospinned to glass slides (Thermo Fisher Scientific, Dreieich, Germany) for 5 min at 1000 rpm. Cells were then fixed with 4% paraformaldehyde at room temperature for 15 min, washed twice with PBS, and permeabilized with 1% Triton X-100 for 10 min at room temperature. Following permeabilization, cells were again washed twice with PBS. Subsequently, blocking buffer (1% BSA + 10% FBS in PBS) was applied to the cells for 1 h. After blocking, the slides were coated with the primary antibody anti-phospho-histone H3 (Ser10) clone 3H10, FITC Conjugate (Merck, Darmstadt, Germany), at a concentration of 4 &#x000b5;g/mL. The slides had been stored in a humid environment at room temperature. After 1 h of staining, the slides were washed three times with PBS, and the cell nuclei were stained with 1 &#x000b5;g/mL of 4&#x02032;,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, Darmstadt, Germany) for 5 min. Slides were then washed three times with PBS. Finally, using an AF7000 widefield fluorescent microscope (Leica Microsystems, Wetzlar, Germany), cells were examined after being coated with Fluoromount-G<sup>&#x000ae;</sup> (SouthernBiotech, Birmingham, AL, USA). FITC was observed at 470/525 nm (excitation/emission wavelengths). DAPI was observed at 470/447 nm (excitation/emission wavelengths) [<a href="#B15-cancers-15-04136" rid="B15-cancers-15-04136" class=" bibr popnode">15</a>].</p></div><div id="sec2dot8-cancers-15-04136" class="sec"><h3 id="sec2dot8-cancers-15-04136title">2.8. Fluorescence Microscopy Imaging of Microtubules Structure</h3><p class="p p-first-last">U2OS human osteosarcoma cells persistently expressing &#x003b1;-tubulin-GFP were grown in a &#x000b5;-Slide 8 Well (30,000 cells/well) (ibidi, Gr&#x000e4;felfing, Germany). Cells were incubated overnight in a 5% CO<sub>2</sub>/37 &#x000b0;C incubator. Afterwards, cells were exposed to different adapalene concentrations (1 &#x000d7; IC<sub>50</sub> or 2 &#x000d7; IC<sub>50</sub>) or media for 48 h. Cells were then rinsed with PBS and Hoechst 33342 Nuclear Stain (BioVision, Wiesbaden, Germany) was added for 30 min at room temperature in the dark to stain cells nuclei. Later on, excess Hoechst stain was removed with PBS, and the slides were coated with Fluoromount-G<sup>&#x000ae;</sup>. Living cells were imaged with AF7000 widefield fluorescence microscope (Leica Microsystems, Wetzlar, Germany). GFP was observed at 470/525 nm (excitation/emission wavelengths). Hoechst stain was observed at 470/447 nm (excitation/emission wavelengths). Finally, the software Fiji ImageJ version 1.8.0_322 (National Institutes of Health, Bethesda, MD, USA) was used to analyze images [<a href="#B33-cancers-15-04136" rid="B33-cancers-15-04136" class=" bibr popnode">33</a>].</p></div><div id="sec2dot9-cancers-15-04136" class="sec"><h3 id="sec2dot9-cancers-15-04136title">2.9. Apoptosis Assessment</h3><p class="p p-first-last">Apoptosis was examined using fluorescein isothiocyanate (FITC)-conjugated annexin V/propidium iodide (PI) assay kit (eBioscience<sup>TM</sup> Annexin V; Invitrogen, San Diego, CA, USA). Briefly, 10<sup>6</sup> of AMO1 cells were seeded in each well of a 6-well plate. Cells were directly treated with three different concentrations of adapalene (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, 2 &#x000d7; IC<sub>50</sub>) or DMSO (used as solvent control), or the positive control bortezomib (1&#x000b5;M) for 48 and 72 h. Subsequently, cells were collected and washed twice; the first time with cold PBS and the second time with annexin binding buffer (1&#x000d7;). After centrifuging the cells at 1500 rpm, 5 &#x003bc;L of fluorochrome-conjugated annexin V were applied to the cells, and the mixture was then incubated at room temperature for 15 min. PI staining solution (2.5 &#x000b5;L of PI diluted in 400 &#x000b5;L binding buffer (1&#x000d7;)) was used to stain the cells. Apoptosis was assessed using an Accuri C6 flow cytometer (Becton-Dickinson, Heidelberg, Germany). A 530/30 nm band pass filter was used to detect the annexin V-FITC signal after being excited at 488 nm. A 610/20 nm band pass filter was used to detect PI signal after being excited at 561 nm. The F- (forward) and S- (side) scatters gated living cells and the A- (area) and W- (width) scatters gated singlets. 10<sup>4</sup> events/sample were documented from the F- (forward) and S- (side) scatters. Cytograhs were obtained with with FlowJo V10.6.2 software (Becton Dickinson) [<a href="#B34-cancers-15-04136" rid="B34-cancers-15-04136" class=" bibr popnode">34</a>].</p></div><div id="sec2dot10-cancers-15-04136" class="sec"><h3 id="sec2dot10-cancers-15-04136title">2.10. Autophagy Examination</h3><p class="p p-first-last">Autophagy was assessed using the autophagy detection kit (ab139484, Abcam, Cambridge, UK). Briefly, 10<sup>6</sup> of AMO1 cells were seeded in each well of a 6-well plate. Cells were directly treated with 3 different concentrations of adapalene (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, 2 &#x000d7; IC<sub>50</sub>) or DMSO (used as solvent control) for 48 and 72 h. The positive control rapamycin (500 nM) was added 18 h prior to detection. Subsequently, cells were collected, washed with PBS, and suspended in 250 &#x000b5;L of PBS supplemented with 5% FBS. Following that, 250 &#x000b5;L of the diluted green stain solution (1 &#x000b5;L of green detection reagent was diluted in 999 &#x000b5;L of PBS supplemented with 5% FBS) was added to each sample for 30 min at 37 &#x000b0;C in dark. Afterwards, the cells were collected by centrifugation, washed with 1&#x000d7; assay buffer, and resuspended with 500 &#x000b5;L of 1&#x000d7; assay buffer. Autophagy was assessed using an Accouri C6 flow cytometer (Becton-Dickinson, Heidelberg, Germany). A 530/30 nm band pass filter was used to detect the green detection reagent after being excited at 488 nm. The F- (forward) and S- (side) scatters gated living cells and the A- (area) and W- (width) scatters gated singlets. 10<sup>4</sup> events/sample were documented from the F- (forward) and S- (side) scatters. Cytographs were obtained with FlowJo V10.6.2 software (Becton-Dickinson, Heidelberg, Germany) [<a href="#B35-cancers-15-04136" rid="B35-cancers-15-04136" class=" bibr popnode">35</a>].</p></div><div id="sec2dot11-cancers-15-04136" class="sec"><h3 id="sec2dot11-cancers-15-04136title">2.11. Western Blot</h3><p class="p p-first-last">Aliquots of 10<sup>6</sup> of AMO1 cells were seeded in each well of a 6-well plate and subjected to various concentrations of adapalene (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, or 2 &#x000d7; IC<sub>50</sub>) or with the negative control DMSO for 48 h at 5% CO<sub>2</sub>/37 &#x000b0;C. Cells were then collected and washed twice with PBS. Total protein extraction was accomplished by suspending the cells in M-PER<sup>&#x000ae;</sup> Mammalian Protein Extraction Reagent supplemented with 1% Halt&#x02122; Protease Inhibitor Cocktail (Thermo Scientific, Frankfurt, Germany) and incubated in a 500-rpm shaker at 4 &#x000b0;C for 30 min. Afterwards, the proteins in the supernatant were collected by centrifuging the cells at 1500 rpm at 4 &#x000b0;C for 15 min. A NanoDrop 1000 spectrophotometer (Thermo Scientific, Frankfurt, Germany) was used to determine protein concentration. Following that, 30 &#x000b5;g of proteins were loaded to each loading well of an SDS-PAGE gel (10%). Proteins were transferred onto a polyvinylidene difluoride (PVDF) membrane after being separated by migration in the separating gel. The membrane was then soaked in blocking buffer (5% BSA in TBST) at room temperature for 1 h. Subsequently, membranes were incubated at 4 &#x000b0;C overnight with primary antibodies (1:1000) against c-MYC (#9402), Phospho-Histone H2A.X (Ser139) (20E3) (#9718), GAPDH (D16H11) XP<sup>&#x000ae;</sup> (#5174), and &#x003b2;-Actin (13E5) (#4970), which were obtained from Cell Signaling Technology (Frankfurt a. M., Germany), and P62 (18420-1-AP), which was obtained from Proteintech (Planegg-Martinsried, Germany). After being washed three times with TBST for 10 min each, membranes were incubated with the proper secondary antibody conjugated with horseradish peroxidase (1:1000) at room temperature for 1 h. Lastly, membranes were photographed using an Alpha Innotech FluorChem Q system (Biozym, Oldendorf, Germany) after being treated with Luminata&#x02122; Classico Western HRP substrate (Merck Millipore, Darmstadt, Germany) for 3 min. ImageJ was used to calculate protein expression [<a href="#B36-cancers-15-04136" rid="B36-cancers-15-04136" class=" bibr popnode">36</a>]. Original, uncropped Western blot membranes can be found in <a href="#app1-cancers-15-04136" rid="app1-cancers-15-04136" class=" app">Supplementary Figures S1&#x02013;S5</a>.</p></div><div id="sec2dot12-cancers-15-04136" class="sec sec-last"><h3 id="sec2dot12-cancers-15-04136title">2.12. T-ALL Xenograft Zebrafish Model</h3><p class="p p-first">Adult zebrafish of the wild-type AB strain were ordered from the China Zebrafish Resource Center, Institute of Hydrobiology, China Academy of Science (Wuhan, China) and officially approved by the Association for Assessment and Accreditation of Laboratory Animal Care International (SYXK 2012-0171). 48 h post-fertilization, natural pair-mating procreated zebrafish larvae were grown in an aquaculture space with a photoperiod of 14 h day/10 h night in a row. Zebrafish larvae were nourished with fry flakes (one portion) and live brine shrimps (two portions) every day.</p><p class="p p-last">To establish a T-ALL xenograft zebrafish model, CCRF-CEM cells were labelled with red fluorescence CM-Dil at a ratio of 1:1000. After 48 h post-fertilization, CCRF-CEM labelled cells (200 cells/zebrafish) were microinjected into the larvae yolk sac. Following that, 24 h post-tumor growth, the success of the established model was verified with a fluorescent microscope (AZ100, Nikon, Tokyo, Japan). The zebrafish bearing the labelled CCRF-CEM cells were then subjected to different adapalene concentrations, or the positive control cis-platinum for 24 h. The fluorescence intensity (Fi) of the tumor mass was measured in each single zebrafish and the inhibitory rate was determined using the following equation [<a href="#B37-cancers-15-04136" rid="B37-cancers-15-04136" class=" bibr popnode">37</a>]:</p><div class="disp-formula"><div class="f">% inhibitory rate = [1 &#x02212; (Fi <sub>treated group</sub>/Fi <sub>negative control group</sub>)] &#x000d7; 100%</div></div><p></p></div></div><div id="sec3-cancers-15-04136" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3-cancers-15-04136title">3. Results</h2><div id="sec3dot1-cancers-15-04136" class="sec sec-first"><h3 id="sec3dot1-cancers-15-04136title">3.1. In Silico Drug Screening</h3><p class="p p-first">In the field of drug development, virtual screening arose as a potent computational method to swipe vast libraries of small molecules for novel chemical hits with desirable features [<a href="#B38-cancers-15-04136" rid="B38-cancers-15-04136" class=" bibr popnode">38</a>]. In the present study, the FDA-approved Zinc 15 database was screened to assess the in silico binding strength of its compounds toward c-MYC using the PyRx0.9 virtual screening tool. More than 100 compounds with predicted binding affinities of less than &#x02212;6.10 kcal/mol were identified by PyRx (<a href="#app1-cancers-15-04136" rid="app1-cancers-15-04136" class=" app">Supplementary Table S1</a>). Subsequently, molecular docking (blind mode) was performed using AutoDock 4.2.6 to validate the outcomes of the virtual drug screening and to examine the preferential binding site of the ligands. The top 100 ligands with the lowest binding energies (LBEs) are depicted in <a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001" co-legend-rid="lgnd_cancers-15-04136-f001"><span>Figure 1</span></a>B (the top 117 ligands with the lowest binding energies (LBEs) are also shown in <a href="#app1-cancers-15-04136" rid="app1-cancers-15-04136" class=" app">Supplementary Table S2</a>). Moreover, a significant correlation (R<sup>2</sup> = 0.9977) was observed between the LBE (kcal/mol) and the predicted pKi values (&#x000b5;M) (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001" co-legend-rid="lgnd_cancers-15-04136-f001"><span>Figure 1</span></a>C).</p><p>Among the top 20 compounds, we focused on atovaquone and adapalene as potential c-MYC inhibitor candidates. The LBE values of atovaquone and adapalene were &#x02212;7.35 kcal/mol and &#x02212;7.27 kcal/mol, respectively (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001" co-legend-rid="lgnd_cancers-15-04136-f001"><span>Figure 1</span></a>D). Interestingly, atovaquone and adapalene exerted stronger binding affinities to c-MYC, if compared to the known c-MYC inhibitors, 10058-F4 and 10074-G5 (LBEs of &#x02212;4.92 kcal/mol and &#x02212;6.24 kcal/mol, respectively) (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001" co-legend-rid="lgnd_cancers-15-04136-f001"><span>Figure 1</span></a>D). It is noteworthy that atovaquone bound to the same binding cavity as 10058-F4. Moreover, adapalene and 10074-G5 bound to the same binding pocket, and the amino acid residue PRO938 was involved in binding to both substances (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001" co-legend-rid="lgnd_cancers-15-04136-f001"><span>Figure 1</span></a>D and <a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f002/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f002" rid-ob="ob-cancers-15-04136-f002" co-legend-rid="lgnd_cancers-15-04136-f002"><span>Figure 2</span></a>).</p><p class="p p-last">All compounds had one amino acid involved in H-bonding except for adapalene, which had two amino acids engaged in H-bonding (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f001/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f001" rid-ob="ob-cancers-15-04136-f001" co-legend-rid="lgnd_cancers-15-04136-f001"><span>Figure 1</span></a>D). The molecular docking further showed that atovaquone and adapalene strongly bound to the bHLHZip domain of c-MYC.</p></div><div id="sec3dot2-cancers-15-04136" class="sec"><h3 id="sec3dot2-cancers-15-04136title">3.2. Effectiveness of Atovaquone and Adapalene against HL60 and U266 Cells</h3><p class="p p-first">Based on the COSMIC database (<a href="https://cancer.sanger.ac.uk/cosmic">https://cancer.sanger.ac.uk/cosmic</a>, accessed on 25 October 2019), HL60 acute myeloid leukemia cells (AML) overexpress c-MYC. On the contrary, Holien et al. (2012) showed that U266 MM cells lack c-MYC expression [<a href="#B39-cancers-15-04136" rid="B39-cancers-15-04136" class=" bibr popnode">39</a>]. To assert these findings, c-MYC protein expression in both cell lines was assessed by us. Our results revealed that HL-60 truly overexpressed c-MYC, while U266 slightly expressed c-MYC. Thus, our U266 findings were contradictory to those of Holien et al. (2012). In our hands, the c-MYC expression is 3&#x000d7; greater in HL-60 than in U266 cells (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f003/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f003" rid-ob="ob-cancers-15-04136-f003" co-legend-rid="lgnd_cancers-15-04136-f003"><span>Figure 3</span></a>A). In an attempt to examine the specificity of atovaquone and adapalene to c-MYC, we evaluated the cytotoxic effect of atovaquone and adapalene in HL60 and U266 cells, respectively. As expected, HL60 cells overexpressing c-MYC were more susceptible to adapalene and atovaquone than U266 cells that had only a modest c-MYC expression. Moreover, HL60 displayed a greater sensitivity to adapalene (IC<sub>50</sub> = 1.19 &#x000b1; 0.17 &#x000b5;M) compared to atovaquone (IC<sub>50</sub> = 19.54 &#x000b1; 2.26 &#x000b5;M) (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f003/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f003" rid-ob="ob-cancers-15-04136-f003" co-legend-rid="lgnd_cancers-15-04136-f003"><span>Figure 3</span></a>B). Therefore, we proceeded with our experiments with adapalene as a potential c-MYC inhibitor candidate.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f003" co-legend-rid="lgnd_cancers-15-04136-f003"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f003/" target="figure" rid-figpopup="cancers-15-04136-f003" rid-ob="ob-cancers-15-04136-f003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620269036240"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620269036240"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f003"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f003/" target="figure" rid-figpopup="cancers-15-04136-f003" rid-ob="ob-cancers-15-04136-f003">Figure 3</a></div><!--caption a7--><div class="caption"><p>Specificity of atovaquone and adapalene towards c-MYC. (<strong>A</strong>) Assessment of c-MYC protein expression in HL60 and U266 cells by western blot. c-MYC protein expression was three times higher in HL-60 than in U266 cells. The bar diagram was obtained by calculating the mean value &#x000b1; SD of three independent experiments. (<strong>B</strong>) The cytotoxic effect of atovaquone and adapalene in HL-60 and U266 cells. HL60 cells were more susceptible to adapalene and atovaquone than U266 cells. HL60 cells displayed a greater sensitivity to adapalene than to atovaquone. Adapalene showed higher specificity to c-MYC. (<strong>C</strong>) Binding of adapalene to recombinant human c-MYC as measured by microscale thermophoresis (MST). The fluorescence signal changed depending on the concentration as shown by the binding curve. The law of mass action was used to obtain fitness. MST was conducted with 70% LED power and 10% MST power.</p></div></div></div><!--fig ft0--><!--fig @position="anchor" mode=article f4--><!--fig mode="anchored" f5--><div class="fig  iconblock anchored whole_rhythm" id="cancers-15-04136-f002"><h3>Figure 2</h3><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620234114016"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620234114016"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f002/?report=objectonly">Open in a separate window</a></div><!--caption a7--><div class="caption"><p>Molecular docking of atovaquone, adapalene, and the known c-MYC:MAX interaction inhibitors: 10058-F4 and 10074-G5. (<strong>A</strong>) Crystal structure of c-MYC (grey) bound to E-Box DNA (pink) (PDB ID: 1NKP). Atovaquone and adapalene shared the same binding cavity as the known inhibitors. (<strong>B</strong>) Amino acids residues expected to be involved in the interaction between c-MYC (grey) and 10058-F4 (orange), 10074-G5 (blue), atovaquone (red), as well as adapalene (yellow), were generated using Discovery Studio Visualizer software (version v.21.1.0.20298).</p></div></div></div><div id="sec3dot3-cancers-15-04136" class="sec"><h3 id="sec3dot3-cancers-15-04136title">3.3. Adapalene Strongly Bound to c-MYC</h3><p class="p p-first-last">MST is a sensitive approach to confirm the interaction between an unlabeled ligand and a labelled protein [<a href="#B40-cancers-15-04136" rid="B40-cancers-15-04136" class=" bibr popnode">40</a>]. Therefore, we performed MST to verify the in silico predicted binding of adapalene to c-MYC. The fluorescence-labeled recombinant human c-MYC protein was titrated against several adapalene concentrations (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f003/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f003" rid-ob="ob-cancers-15-04136-f003" co-legend-rid="lgnd_cancers-15-04136-f003"><span>Figure 3</span></a>C). A fit curve was accomplished in accordance with the law of mass action, and adapalene was shown to robustly bind to c-MYC with a K<sub>d</sub> value of 3.05 &#x000b5;M. The MST findings were in line with those of the in silico results.</p></div><div id="sec3dot4-cancers-15-04136" class="sec"><h3 id="sec3dot4-cancers-15-04136title">3.4. Adapalene Reduced the Viability of Hematological Cancer Cells</h3><p class="p p-first-last">c-MYC plays a crucial role in MM pathophysiology [<a href="#B41-cancers-15-04136" rid="B41-cancers-15-04136" class=" bibr popnode">41</a>]. Given that adapalene might be a novel potential c-MYC inhibitor that has not yet been reported as a therapy for hematological malignancies, we examined the cytotoxic effect of adapalene in MM, T-ALL, and PBMCs using the resazurin cell viability assay. After 72 h of treatment, all evaluated MM cell lines showed substantial sensitivity towards adapalene. The most sensitive cell line, AMO1, had an IC<sub>50</sub> value of 1.76 &#x000b1; 0.39 &#x000b5;M, while the least sensitive cell line, JJN3, had an IC<sub>50</sub> value of 9.10 &#x000b1; 1.85 &#x000b5;M (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f004/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f004" rid-ob="ob-cancers-15-04136-f004" co-legend-rid="lgnd_cancers-15-04136-f004"><span>Figure 4</span></a> and <a href="/pmc/articles/PMC10452460/table/cancers-15-04136-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-t001" rid-ob="ob-cancers-15-04136-t001" co-legend-rid=""><span>Table 1</span></a>). Moreover, CCRF-CEM and CEM/ADR5000 cells were sensitive to adapalene to nearly a similar extent (IC<sub>50</sub> = 1.83 &#x000b1; 0.46 &#x000b5;M and 2.30 &#x000b1; 0.09 &#x000b5;M, respectively). Therefore, multidrug-resistant CEM/ADR5000 cells were not cross-resistant to this drug (degree of resistance: 1.26). The concentration of adapalene needed to inhibit the viability of JJN3 cells (the least sensitive cell line) by 50% was lower than the concentration required to inhibit 50% of healthy leucocytes (IC<sub>50</sub> = 36.72 &#x000b1; 0.64 &#x000b5;M) (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f004/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f004" rid-ob="ob-cancers-15-04136-f004" co-legend-rid="lgnd_cancers-15-04136-f004"><span>Figure 4</span></a> and <a href="/pmc/articles/PMC10452460/table/cancers-15-04136-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-t001" rid-ob="ob-cancers-15-04136-t001" co-legend-rid=""><span>Table 1</span></a>), indicating at least some tumor specificity of this compound.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f004" co-legend-rid="lgnd_cancers-15-04136-f004"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f004/" target="figure" rid-figpopup="cancers-15-04136-f004" rid-ob="ob-cancers-15-04136-f004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620226599568"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620226599568"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f004"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f004/" target="figure" rid-figpopup="cancers-15-04136-f004" rid-ob="ob-cancers-15-04136-f004">Figure 4</a></div><!--caption a7--><div class="caption"><p>Adapalene&#x02019;s cytotoxic effect in various human MM cell lines (AMO1, KMS12BM, MolP8, NCI-H929, RPMI8226, OPM2, KMS11, L363, and JJN3), in human T-ALL cells (CEM/ADR5000 and CCRF/CEM), and in peripheral blood mononuclear cells (PBMCs). Each value indicates the mean value &#x000b1; SD of three distinct experiments, each of which had six replicates.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="cancers-15-04136-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Adapalene&#x02019;s IC<sub>50</sub> values in MM, drug-sensitive T-ALL, and their multidrug-resistant P-glycoprotein-overexpressing leukemia sublines, as well as healthy leukocytes.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub> (&#x000b5;M)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">MM</td><td align="center" valign="middle" rowspan="1" colspan="1">AMO1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.76 &#x000b1; 0.39</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">KMS12BM</td><td align="center" valign="middle" rowspan="1" colspan="1">2.61 &#x000b1; 0.36</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">MOLP8</td><td align="center" valign="middle" rowspan="1" colspan="1">2.69 &#x000b1; 0.29</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">NCI-H929</td><td align="center" valign="middle" rowspan="1" colspan="1">4.95 &#x000b1; 1.21</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">RPMI8226</td><td align="center" valign="middle" rowspan="1" colspan="1">4.97 &#x000b1; 1.33</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">OPM2</td><td align="center" valign="middle" rowspan="1" colspan="1">5.82 &#x000b1; 2.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">KMS11</td><td align="center" valign="middle" rowspan="1" colspan="1">7.22 &#x000b1; 1.20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">L363</td><td align="center" valign="middle" rowspan="1" colspan="1">7.25 &#x000b1; 0.73</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">JJN3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.10 &#x000b1; 1.85</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Leukemia</td><td align="center" valign="middle" rowspan="1" colspan="1">CCRF-CEM </td><td align="center" valign="middle" rowspan="1" colspan="1">1.83 &#x000b1; 0.46</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CEM/ADR5000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.30 &#x000b1; 0.09</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Normal leukocytes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PBMCs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.72 &#x000b1; 0.64</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140620235553760"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/table/cancers-15-04136-t001/?report=objectonly">Open in a separate window</a></div></div></div><div id="sec3dot5-cancers-15-04136" class="sec"><h3 id="sec3dot5-cancers-15-04136title">3.5. Adapalene Inhibited c-MYC Expression and Transcriptional Activity In Vitro</h3><p class="p p-first-last">Based on the in silico and MST results, we wanted to further confirm the hypothesis that adapalene may be a c-MYC inhibitor. Therefore, we investigated whether adapalene impeded c-MYC expression and transcriptional activity. Adapalene treatment considerably and dose-dependently downregulated c-MYC expression (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f005/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f005" rid-ob="ob-cancers-15-04136-f005" co-legend-rid="lgnd_cancers-15-04136-f005"><span>Figure 5</span></a>A). In an effort to evaluate whether adapalene&#x02019;s inhibitory effect was not just confined to c-MYC expression but might possibly also involve the inhibition of c-MYC transcriptional activity, a c-MYC reporter luciferase construct was transfected into HEK293 cells. These cells were then subjected to various concentrations of adapalene and 10058-F4, a known c-MYC inhibitor, respectively. Indeed, adapalene dose-dependently suppressed the transcriptional activity of c-MYC. Interestingly, low adapalene concentrations suppressed c-MYC activity more effectively than the established inhibitor 10058-F4, demonstrating the strong c-MYC inhibitory potential of adapalene (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f005/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f005" rid-ob="ob-cancers-15-04136-f005" co-legend-rid="lgnd_cancers-15-04136-f005"><span>Figure 5</span></a>B).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f005" co-legend-rid="lgnd_cancers-15-04136-f005"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f005/" target="figure" rid-figpopup="cancers-15-04136-f005" rid-ob="ob-cancers-15-04136-f005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620226592000"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620226592000"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f005"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f005/" target="figure" rid-figpopup="cancers-15-04136-f005" rid-ob="ob-cancers-15-04136-f005">Figure 5</a></div><!--caption a7--><div class="caption"><p>Adapalene affected c-MYC expression and transcriptional activity. (<strong>A</strong>) Effect of adapalene (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, and 2 &#x000d7; IC<sub>50</sub>) on c-MYC protein expression in AMO1 cells as displayed by western blot. The bar diagram was created by calculating the mean value &#x000b1; SD of three independent experiments. The uncropped bolts are shown in <a href="#app1-cancers-15-04136" rid="app1-cancers-15-04136" class=" app">Supplementary Materials Figure S2</a>. (<strong>B</strong>) Effect of adapalene and 10058-F4, a known c-MYC inhibitor, on c-MYC transcriptional activity. The bar diagram represents the percentage of normalized c-MYC activity in HEK293 cells transiently expressing a c-MYC-luciferase reporter construct. It was created by calculating the mean value &#x000b1; SD of two independent experiments. * <em>p</em> &#x0003c; 0.05, ** <em>p</em> &#x0003c; 0.01, if compared to negative control.</p></div></div></div></div><div id="sec3dot6-cancers-15-04136" class="sec"><h3 id="sec3dot6-cancers-15-04136title">3.6. Cell Cycle Investigations in Adapalene-Treated AMO1 Cells</h3><p class="p p-first-last">Many cytotoxic substances exert their anticancer activities by affecting the cell cycle progression of cancer cells [<a href="#B20-cancers-15-04136" rid="B20-cancers-15-04136" class=" bibr popnode">20</a>]. To examine the impact on the cell cycle in AMO1 cells, we incubated the cells for 48 and 72 h with various adapalene concentrations (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, and 2 &#x000d7; IC<sub>50</sub>). The percentage of AMO1 cells in the G2/M (indicating mitotic arrest) and sub-G0/G1 phases (indicating cell death) increased in direct proportion with increasing adapalene concentrations (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f006/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f006" rid-ob="ob-cancers-15-04136-f006" co-legend-rid="lgnd_cancers-15-04136-f006"><span>Figure 6</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f006" co-legend-rid="lgnd_cancers-15-04136-f006"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f006/" target="figure" rid-figpopup="cancers-15-04136-f006" rid-ob="ob-cancers-15-04136-f006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620226581120"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620226581120"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f006"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f006/" target="figure" rid-figpopup="cancers-15-04136-f006" rid-ob="ob-cancers-15-04136-f006">Figure 6</a></div><!--caption a7--><div class="caption"><p>Cell cycle perturbations of AMO1 cells by adapalene. (<strong>A</strong>&#x02013;<strong>C</strong>) Gating scheme: (<strong>A</strong>) The first gate (SSC-A vs. FSC-A) intends to get rid of the debris. (<strong>B</strong>) The second gate (FSC-H vs. FSC-A) aims to select only single cells. (<strong>C</strong>) Count vs. FL2-A represents cell cycle histograms. (<strong>D</strong>,<strong>E</strong>) DNA histograms of AMO1 exposed to adapalene (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, and 2 &#x000d7; IC<sub>50</sub>) for 48 h (<strong>D</strong>) and 72 h (<strong>E</strong>). The histograms were obtained by flow cytometry using an excitation and an emission wavelength of 488 and 530 nm, respectively. (<strong>F</strong>,<strong>G</strong>) The bar diagrams showing the distribution of AMO1 cells treated with adapalene in the distinct phases of the cell cycle after 48 h (<strong>F</strong>) and 72 h (<strong>G</strong>) were created by calculating the mean value &#x000b1; SD of two independent experiments. * <em>p</em> &#x0003c; 0.05, ** <em>p</em> &#x0003c; 0.01 if compared to negative control.</p></div></div></div></div><div id="sec3dot7-cancers-15-04136" class="sec"><h3 id="sec3dot7-cancers-15-04136title">3.7. Adapalene Induced Mitotic Arrest as Detected by Phospho-Histone-3 (Ser10) Immunofluorescence</h3><p class="p p-first-last">Phospho-histone-3 (Ser10) (p-H3(Ser10)) represents a cell cycle marker to assess cells in the late G2/M phase [<a href="#B42-cancers-15-04136" rid="B42-cancers-15-04136" class=" bibr popnode">42</a>]. To confirm whether adapalene induced G2 or M arrest, we examined the effect of adapalene on the expression of p-H3(Ser10), a mitotic hallmark that is crucial in regulating the mitotic catastrophe [<a href="#B43-cancers-15-04136" rid="B43-cancers-15-04136" class=" bibr popnode">43</a>]. Adapalene significantly increased the expression of p-H3(Ser10) in AMO1 cells after treatment for 48 h (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f007/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f007" rid-ob="ob-cancers-15-04136-f007" co-legend-rid="lgnd_cancers-15-04136-f007"><span>Figure 7</span></a>). Therefore, adapalene indeed induced the accumulation of AMO1 cells in the M-phase.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f007" co-legend-rid="lgnd_cancers-15-04136-f007"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f007/" target="figure" rid-figpopup="cancers-15-04136-f007" rid-ob="ob-cancers-15-04136-f007"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620230628496"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g007.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g007.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620230628496"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f007/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f007"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f007/" target="figure" rid-figpopup="cancers-15-04136-f007" rid-ob="ob-cancers-15-04136-f007">Figure 7</a></div><!--caption a7--><div class="caption"><p>Accumulation of positive p-H3(Ser10) in AMO1 cells treated with adapalene (1 &#x000d7; IC<sub>50</sub> and 2 &#x000d7; IC<sub>50</sub>) or DMSO (control) for 48 h. Anti-phospho-histone H3 (Ser10) clone 3H10, FITC-conjugated antibody (green), was used for immunostaining AMO1 cells. DAPI (blue) was used for nuclear staining. An AF7000 widefield fluorescence microscope at 40&#x000d7; magnification (scale bars = 20 &#x000b5;m) was used for imaging. The bar diagram represents the percentage of positive p-H3(Ser10). ** <em>p</em> &#x0003c; 0.01, *** <em>p</em> &#x0003c; 0.001 if compared to negative control.</p></div></div></div></div><div id="sec3dot8-cancers-15-04136" class="sec"><h3 id="sec3dot8-cancers-15-04136title">3.8. Adapalene Mitotic Arrest Involved the Distortion of the Tubulin Network as Detected by Immunofluorescence</h3><p class="p p-first-last">Mitotic arrest is most likely caused by the suppression of microtubule polymerization because microtubules are essential for chromosomal separation during mitosis [<a href="#B44-cancers-15-04136" rid="B44-cancers-15-04136" class=" bibr popnode">44</a>]. Considering that adapalene led to G2/M arrest, we examined its impact on the tubulin network. U2OS cells stably transfected with &#x003b1;-tubulin-GFP fusion construct were treated with adapalene (1 &#x000d7; IC<sub>50</sub> and 2 &#x000d7; IC<sub>50</sub>) for 48 h, and the tubulin network was visualized by confocal microscopy. Control cells perfectly polymerized the tubulin network. This was demonstrated by the significant amount of tubulin that disseminated throughout the cytoplasm and produced a strong intracellular network. By contrast, the tubulin network appeared in a chaotic shape upon adapalene treatment. Adapalene expanded the tubulin mass surrounding the nucleus while decreasing the growth of microtubules at the borders. Additionally, adapalene-treated cells displayed fragile microtubules at their borders if compared to control cells (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f008/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f008" rid-ob="ob-cancers-15-04136-f008" co-legend-rid="lgnd_cancers-15-04136-f008"><span>Figure 8</span></a>). Comparing adapalene&#x02019;s effect to positive the control drugs nocodazole (as polymerization inhibitor) and paclitaxel (as depolymerization inhibitor) [<a href="#B45-cancers-15-04136" rid="B45-cancers-15-04136" class=" bibr popnode">45</a>] allowed us to conclude that adapalene prevented the polymerization of the microtubule network in a manner similar to nocodazole.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f008" co-legend-rid="lgnd_cancers-15-04136-f008"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f008/" target="figure" rid-figpopup="cancers-15-04136-f008" rid-ob="ob-cancers-15-04136-f008"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620230624112"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g008.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g008.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g008.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620230624112"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f008/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f008"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f008/" target="figure" rid-figpopup="cancers-15-04136-f008" rid-ob="ob-cancers-15-04136-f008">Figure 8</a></div><!--caption a7--><div class="caption"><p>Chaotic microtubule network in U2OS cells stably transfected with GFP-&#x003b1;-tubulin protein upon adapalene treatment (1 &#x000d7; IC<sub>50</sub> and 2 &#x000d7; IC50) for 48 h. U2OS cells were fixed with 4% paraformaldehyde. Micrographs were snapped 48 h after treatment with DMSO or adapalene treatment (1 &#x000d7; IC<sub>50</sub> and 2 &#x000d7; IC<sub>50</sub>). DAPI (blue) was used for nuclear staining. The peripheral tubulin masses are pointed out with white arrows. An AF7000 widefield fluorescence microscope at 40&#x000d7; magnification (scale bars = 7 &#x000b5;m) was used for imaging.</p></div></div></div></div><div id="sec3dot9-cancers-15-04136" class="sec"><h3 id="sec3dot9-cancers-15-04136title">3.9. Adapalene Induced Apoptosis, Autophagy, and DNA Damage in AMO1 Cells</h3><p class="p p-first">Our cell cycle results showed a dramatical dose-dependent increase in the fraction of cells in the sub-G0/G1 phase, indicating that adapalene promoted cell death. In an effort to determine the cell death mode(s) induced by adapalene, we studied the three main processes of cell death: apoptosis (type I), autophagy (type II), and necrosis (type III) [<a href="#B46-cancers-15-04136" rid="B46-cancers-15-04136" class=" bibr popnode">46</a>]. First, we investigated apoptosis, a form of programmed cell death that most likely takes place in cancer cells treated with cytotoxic drugs. A FITC-conjugated annexin V/PI assay was used to distinguish between living, early apoptotic, late apoptotic, and necrotic cells. Annexin V is usually detected in early and late apoptosis. However, PI is detected in late apoptosis and necrosis. The positive control drug bortezomib effectively induced early and late apoptotic cells after 48 h treatment. Increasing the incubation period to 72 h considerably induced early apoptotic cells without significantly affecting the portion of late apoptotic cells. The number of early and late apoptotic cells significantly increased in a dose-dependent manner upon treatment with adapalene for 48 h. Interestingly, extending the incubation time to 72 h did not considerably change the proportion of apoptotic cells. Moreover, necrotic cells were not detected at all (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f009/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f009" rid-ob="ob-cancers-15-04136-f009" co-legend-rid="lgnd_cancers-15-04136-f009"><span>Figure 9</span></a>), indicating that adapalene induced apoptosis in a comparable manner after 48 and 72 h.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f009" co-legend-rid="lgnd_cancers-15-04136-f009"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f009/" target="figure" rid-figpopup="cancers-15-04136-f009" rid-ob="ob-cancers-15-04136-f009"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620230615680"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g009.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g009.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g009.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620230615680"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f009/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f009"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f009/" target="figure" rid-figpopup="cancers-15-04136-f009" rid-ob="ob-cancers-15-04136-f009">Figure 9</a></div><!--caption a7--><div class="caption"><p>Induction of apoptosis in adapalene-treated AMO1 cells. (<strong>A</strong>,<strong>B</strong>) Apoptosis was examined in AMO1 cells treated with adapalene after 48 h (<strong>A</strong>) and 72 h (<strong>B</strong>) using annexin V/PI staining. Q4 represents viable cells (&#x02212;) annexin V/(&#x02212;) PI; Q3 represents early apoptotic cells (+) annexin V/(&#x02212;) PI; Q2 represents late apoptotic cells exhibit annexin V (+)/PI (+); Q1 represents necrotic cells (&#x02212;) annexin V/(+) PI. Treatment with adapalene at increasing concentrations greatly enhanced the percentage of early and late apoptotic cells after 48 and 72 h. (<strong>C</strong>,<strong>D</strong>) The bar diagrams showing the distribution of AMO1 cells in the different quadrants after 48 h (<strong>C</strong>) and 72 h (<strong>D</strong>) were created by calculating the mean value &#x000b1; SD of three trials conducted at distinct times. * <em>p</em> &#x0003c; 0.05, ** <em>p</em> &#x0003c; 0.01, *** <em>p</em> &#x0003c; 0.001 if compared to negative control.</p></div></div></div><p>Next, we examined autophagy as a type II cell death modality. Autophagy detection using flow cytometry revealed that the untreated control cells displayed a weak fluorescence signal. However, the intensity of this signal increased proportionally with increasing adapalene concentrations, reaching an approximately 1.7-fold increase with 2 &#x000d7; IC<sub>50</sub> after 48 h treatment. Interestingly, adapalene induced autophagy more significantly than rapamycin, a common autophagy inducer (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f010/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f010" rid-ob="ob-cancers-15-04136-f010" co-legend-rid="lgnd_cancers-15-04136-f010"><span>Figure 10</span></a>A). Adapalene continued to trigger autophagy after 72 h treatment, albeit to a lower extent if compared to 48 h post-treatment (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f010/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f010" rid-ob="ob-cancers-15-04136-f010" co-legend-rid="lgnd_cancers-15-04136-f010"><span>Figure 10</span></a>B), suggesting a potential switch to another type of cell death. To strengthen our conclusions, we further examined autophagy by detecting the autophagic markers Beclin1 and LC3BII by Western blotting after 48 h treatment. Western blot analyses showed that the protein expression level of Beclin1 and LC3BII increased if AMO1 cells were treated with 0.5 &#x000d7; IC<sub>50</sub> and 1&#x000d7; IC<sub>50</sub> of adapalene. However, Beclin1 and LC3BII expression diminished upon treatment with 2 &#x000d7; IC<sub>50</sub> (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f010/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f010" rid-ob="ob-cancers-15-04136-f010" co-legend-rid="lgnd_cancers-15-04136-f010"><span>Figure 10</span></a>C), indicating that adapalene prompted autophagy.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f010" co-legend-rid="lgnd_cancers-15-04136-f010"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f010/" target="figure" rid-figpopup="cancers-15-04136-f010" rid-ob="ob-cancers-15-04136-f010"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620235562384"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g010.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g010.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g010.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620235562384"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f010/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f010"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f010/" target="figure" rid-figpopup="cancers-15-04136-f010" rid-ob="ob-cancers-15-04136-f010">Figure 10</a></div><!--caption a7--><div class="caption"><p>Induction of DNA damage and autophagy in adapalene-treated AMO1 cells. (<strong>A</strong>,<strong>B</strong>) Autophagy was examined in AMO1 cells treated with adapalene after 48 h (<strong>A</strong>) and 72 h (<strong>B</strong>) using green detection reagent. The histograms overlays were obtained by flow cytometry using an excitation and an emission wavelength of 463 and 534 nm, respectively. The bar diagrams were created by calculating the mean value &#x000b1; SD of three trials conducted at distinct times. (<strong>C</strong>) Effect of adapalene (0.5 &#x000d7; IC<sub>50</sub>, 1 &#x000d7; IC<sub>50</sub>, and 2 &#x000d7; IC<sub>50</sub>) on the protein expression levels of &#x003b3;H2AX, Beclin 1, and LC3-II in AMO1 cells as detected by western blot. The bar diagram was created by calculating the mean value &#x000b1; SD of three trials conducted at distinct times. * <em>p</em> &#x0003c; 0.05, ** <em>p</em> &#x0003c; 0.01, *** <em>p</em> &#x0003c; 0.001 if compared to negative control. The uncropped bolts are shown in <a href="#app1-cancers-15-04136" rid="app1-cancers-15-04136" class=" app">Supplementary Materials Figures S3&#x02013;S5</a>.</p></div></div></div><p class="p p-last">It has been known for many years that DNA double-strand breaks and c-MYC dysregulation are tightly related [<a href="#B47-cancers-15-04136" rid="B47-cancers-15-04136" class=" bibr popnode">47</a>]. Given that &#x003b3;H2AX is a marker of DNA double-strand breaks [<a href="#B48-cancers-15-04136" rid="B48-cancers-15-04136" class=" bibr popnode">48</a>], we determined the &#x003b3;H2AX expression 48 h post-adapalene treatment. Western blot analysis revealed that the &#x003b3;H2AX expression effectively increased in a dose-dependent manner in AMO1 cells (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f010/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f010" rid-ob="ob-cancers-15-04136-f010" co-legend-rid="lgnd_cancers-15-04136-f010"><span>Figure 10</span></a>C), suggesting that adapalene triggered DNA damage.</p></div><div id="sec3dot10-cancers-15-04136" class="sec sec-last"><h3 id="sec3dot10-cancers-15-04136title">3.10. Anticancer Activity of Adapalene In Vivo</h3><p class="p p-first-last">The anti-tumor efficacy of adapalene has been confirmed in vivo using murine models [<a href="#B20-cancers-15-04136" rid="B20-cancers-15-04136" class=" bibr popnode">20</a>,<a href="#B22-cancers-15-04136" rid="B22-cancers-15-04136" class=" bibr popnode">22</a>]. In this study, a CCRF-CEM xenograft tumor model was established in larvae zebrafish, and the fluorescence intensity was measured to calculate the tumor inhibition rate after 24 h treatment. Comparing the positive control imatinib mesylate with the untreated group revealed that imatinib mesylate significantly reduced the intensity of the fluorescent CCRF-CEM tumors (<a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f011/" target="figure" class="fig-table-link figpopup" rid-figpopup="cancers-15-04136-f011" rid-ob="ob-cancers-15-04136-f011" co-legend-rid="lgnd_cancers-15-04136-f011"><span>Figure 11</span></a>). The same was true for adapalene, which reduced the growth of CCRF-CEM tumors with an inhibitory rate of 38.23% at 3.47 nM. Even though adapalene has been administrated at an extremely low dose, it nonetheless demonstrated a higher inhibitory rate than the positive control drug. Our investigations revealed that adapalene possessed anti-tumor properties in a larvae zebrafish model.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cancers-15-04136-f011" co-legend-rid="lgnd_cancers-15-04136-f011"><a href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f011/" target="figure" rid-figpopup="cancers-15-04136-f011" rid-ob="ob-cancers-15-04136-f011"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140620235557520"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10452460_cancers-15-04136-g011.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is cancers-15-04136-g011.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10452460/bin/cancers-15-04136-g011.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140620235557520"><a target="object" rel="noopener" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f011/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cancers-15-04136-f011"><div><a class="figpopup" href="/pmc/articles/PMC10452460/figure/cancers-15-04136-f011/" target="figure" rid-figpopup="cancers-15-04136-f011" rid-ob="ob-cancers-15-04136-f011">Figure 11</a></div><!--caption a7--><div class="caption"><p>Examination of the acute cytotoxicity (fluorescence intensity and inhibition rate) of CCRF-CEM xenograft tumor zebrafish model (<em>n</em> = 10 zebrafish) treated with adapalene. The tumor mass of the CCRF-CEM was highlighted by the red fluorescence. Images were captured at a 60&#x000d7; magnification (scale bars = 100 &#x000b5;m). If compared to the model, * <em>p</em> &#x0003c; 0.05, *** <em>p</em> &#x0003c; 0.001 are significant.</p></div></div></div></div></div><div id="sec4-cancers-15-04136" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4-cancers-15-04136title">4. Discussion</h2><p class="p p-first">Despite substantial improvements in MM treatment, this disease is currently regarded as incurable due to relapse and resistance to chemotherapy, highlighting the need for new treatments with alternative approaches [<a href="#B13-cancers-15-04136" rid="B13-cancers-15-04136" class=" bibr popnode">13</a>]. The proto-oncogene c-MYC is considered as an appealing therapeutic target for MM treatment since its dysregulation is a distinctive genetic feature of MM. Numerous strategies suggested so far focus on c-MYC in MM. However, the pharmacokinetics and efficacy of most of these techniques were unsatisfactory, rendering the direct inhibition of c-MYC very challenging in the context of ligand discovery [<a href="#B13-cancers-15-04136" rid="B13-cancers-15-04136" class=" bibr popnode">13</a>]. This fact urged us to search for novel compounds that directly inhibit c-MYC. Therefore, we performed targeted screening of the FDA-approved drug library using in silico tools (virtual screening and molecular docking). Vitamin A, as well as its natural and synthetic analogues, known as retinoids, are essential for several vital processes such as pattern formation in embryogenesis, bone development, hematopoiesis, differentiation, metabolism, reproduction, and vision [<a href="#B49-cancers-15-04136" rid="B49-cancers-15-04136" class=" bibr popnode">49</a>]. Retinoids have shown a strong antiproliferative effect and have been beneficial in the treatment of a number of human disorders, including cancer [<a href="#B50-cancers-15-04136" rid="B50-cancers-15-04136" class=" bibr popnode">50</a>]. Due to their strong gene regulation capability and receptor-binding affinities, retinoids have been widely claimed to possess anticancer activities [<a href="#B51-cancers-15-04136" rid="B51-cancers-15-04136" class=" bibr popnode">51</a>]. In fact, they have demonstrated promising therapeutic results in clinical studies for solid tumors as prostate cancer, basal cell skin cancer, head and neck cancer, renal cancer, cervical cancer, and breast cancer [<a href="#B52-cancers-15-04136" rid="B52-cancers-15-04136" class=" bibr popnode">52</a>]. Moreover, all-trans-retinoic acid (ATRA)-based differentiation therapy has also been very effective in treating acute promyelocytic leukemia (APL) [<a href="#B53-cancers-15-04136" rid="B53-cancers-15-04136" class=" bibr popnode">53</a>]. In comparison to natural retinoids, synthetic retinoids have demonstrated greater selectivity, stronger efficacy, and reduced toxicity [<a href="#B51-cancers-15-04136" rid="B51-cancers-15-04136" class=" bibr popnode">51</a>]. Adapalene belongs the third generation of retinoids [<a href="#B16-cancers-15-04136" rid="B16-cancers-15-04136" class=" bibr popnode">16</a>]. Although it was originally a topical treatment of acne vulgaris [<a href="#B54-cancers-15-04136" rid="B54-cancers-15-04136" class=" bibr popnode">54</a>], we found that it strongly bound to the c-MYC bHLHZip domain at the same binding pocket as the known inhibitor 10074-G5. This binding pocket represents the MYC/MAX interaction site which is essential for the function of c-MYC. As adapalene shared the same binding pocket with 10074-G5, it is presumed that they exhibit similar modes of action. They inhibit c-Myc/Max heterodimer formation and thus inhibit its transcriptional activity. Interestingly, adapalene showed higher affinity to c-MYC if compared to the positive controls 10058-F4 and 10074-G5. Hence, adapalene might be a novel candidate c-MYC inhibitor, and it may be a third-generation retinoid repurposed for the treatment of MM. To validate this hypothesis, we examined the molecular interaction of adapalene and c-MYC using MST. Indeed, adapalene robustly bound to c-MYC (K<sub>d</sub> = 3.05 &#x000b5;M), and these findings were in line with those of the in silico analysis. Next, we investigated the sensitivity of a panel of nine MM cell lines as well as drug-sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells towards adapalene. All MM cell lines responded to adapalene with different degrees of sensitivity (IC<sub>50</sub> values from 1.76 &#x000b1; 0.39 &#x003bc;M to 9.10 &#x000b1; 1.85 &#x003bc;M). Since AMO1 was the most sensitive cell line (IC<sub>50</sub> = 1.76 &#x000b1; 0.39 &#x003bc;M), we investigated the mechanisms of action of adapalene in these cells. It is known that CEM/ADR5000 cells, overexpressing the multidrug-resistance-mediating ABC-transporter P-glycoprotein, extrude chemotherapeutic drugs out of cells resulting in chemotherapy failure [<a href="#B55-cancers-15-04136" rid="B55-cancers-15-04136" class=" bibr popnode">55</a>,<a href="#B56-cancers-15-04136" rid="B56-cancers-15-04136" class=" bibr popnode">56</a>]. According to our findings, CEM/ADR5000 cells and their sensitive counterparts both demonstrated a similar level of sensitivity to adapalene. Furthermore, the resistance ratio was just 1.26, which is far lower than that of doxorubicin, a common chemotherapeutic medication with a cross-resistance ratio much more than 1000 [<a href="#B30-cancers-15-04136" rid="B30-cancers-15-04136" class=" bibr popnode">30</a>]. These findings suggested that adapalene is not involved in the cross-resistance profile conferred by P-glycoprotein. The concentration of adapalene needed to inhibit the proliferation of 50% of human peripheral blood mononuclear cells (PBMCs) was much higher than those of all tested leukemia and MM cell lines. This suggests that the concentration of adapalene required to kill leukemia and MM cells might be also reached in patients without harming healthy hematopoietic cells. To the best of our knowledge, we are the first to demonstrate that the retinoid adapalene inhibited MM cells by suppressing c-MYC, suggesting a novel mode of action of adapalene not as an anti-inflammatory but as a potential anticancer agent.</p><p>The oncogene c-MYC is overexpressed in several cancer types, and it is a causative factor of at least 40% of malignancies. On the other hand, c-MYC expression is firmly controlled in healthy cells [<a href="#B57-cancers-15-04136" rid="B57-cancers-15-04136" class=" bibr popnode">57</a>]. c-MYC primarily acts as a transcriptional regulator, modulating the expression of genes that are involved in a variety of cellular activities, including transcription, translation, cell division, metabolism, cell differentiation, DNA repair, apoptosis, autophagy, immune response, and stem cell growth [<a href="#B58-cancers-15-04136" rid="B58-cancers-15-04136" class=" bibr popnode">58</a>]. Its contribution to oncogenesis was initially discovered due to its homology to an avian retrovirus and was highly expressed in Burkitt&#x02019;s lymphoma because of the t(8;14) translocation [<a href="#B59-cancers-15-04136" rid="B59-cancers-15-04136" class=" bibr popnode">59</a>,<a href="#B60-cancers-15-04136" rid="B60-cancers-15-04136" class=" bibr popnode">60</a>]. Moreover, c-MYC deregulation is one of the main features in MM progression. Although targeting c-MYC is challenging, numerous investigations demonstrated the potential significance of c-MYC inhibition for cancer therapy [<a href="#B61-cancers-15-04136" rid="B61-cancers-15-04136" class=" bibr popnode">61</a>]. Currently, no MYC inhibitor has been clinically established, but significant efforts are globally ongoing to realize this possibility for cancer patients [<a href="#B62-cancers-15-04136" rid="B62-cancers-15-04136" class=" bibr popnode">62</a>]. In this context, verifying that adapalene inhibits c-MYC may be a glimmer of hope, especially because it is an FDA-approved drug, and its toxicity profiles, pharmacokinetics, and pharmacodynamics are well established. To further validate adapalene as c-MYC inhibitor, we performed a c-MYC reporter assay. Adapalene significantly reduced the DNA-binding activity of c-MYC. It is interesting to note that this inhibitory impact was substantially stronger than the prominent c-MYC inhibitor 10058-F4. Additionally, adapalene concentrations required to inhibit c-MYC were far lower than that of 10058-F4. Furthermore, adapalene significantly and dose-dependently reduced the expression of c-MYC. Taken together, our in vitro results were in line with those of the in silico data and conclude that adapalene may indeed inhibit c-MYC expression and its transcriptional activity.</p><p>c-MYC activates the expression of genes that are essential regulators of the cell cycle, including E2F transcription factors, cyclins, and cyclin-dependent kinases (CDKs). Additionally, c-MYC inhibits Cdk inhibitors such as p21 and p27 by activating SKP2, which is involved in p27 degradation, or by inhibiting CDKN1A, which codes for p21. Furthermore, c-MYC activates CUL1, a component of the E3 ubiquitin ligase complex necessary for the effective ubiquitination and destruction of p27 [<a href="#B63-cancers-15-04136" rid="B63-cancers-15-04136" class=" bibr popnode">63</a>]. Moreover, inhibiting c-MYC caused human myeloid and lymphoid cells arrest the cell cycle [<a href="#B64-cancers-15-04136" rid="B64-cancers-15-04136" class=" bibr popnode">64</a>]. Given the important role of c-MYC for cell cycle control, we examined the cell cycle progression of adapalene-treated AMO1 cells after 48 and 72 h treatment. Adapalene arrested AMO1 cells in the G2/M phase besides an increase in the sub-G0/G1 phase after 48 and 72 h treatment. To investigate the molecular mechanisms underlying the G2/M phase arrest, immunofluorescence microscopy was performed to determine the number of adapalene-treated AMO1 cells that were positive for p-H3(Ser10). Indeed, adapalene treatment caused AMO1 cells to preferentially assemble in the M-phase. Given that Ser10 phosphorylation occurs in early prophase, is maintained during metaphase, is decreased during anaphase, and vanishes entirely during telophase before or at the start of chromosomal decondensation [<a href="#B65-cancers-15-04136" rid="B65-cancers-15-04136" class=" bibr popnode">65</a>], an increase in the number of positive p-H3(Ser10) represents an indication of adapalene&#x02019;s ability to hamper mitotic exit in AMO1 cells. Usually, mitotic catastrophe is the most prevalent outcome of extended mitotic arrest. It is a mechanism that senses mitotic failure and responds by initiating irreparable, anti-proliferative cell death [<a href="#B66-cancers-15-04136" rid="B66-cancers-15-04136" class=" bibr popnode">66</a>]. This may account for the time- and dose-dependent increase of cells in the sub-G0/G1 phase. Our results unexpectedly differed from those of other studies where adapalene induced S-phase arrest in a prostate cancer cell, a triple-negative breast cancer cell, and melanoma cells [<a href="#B22-cancers-15-04136" rid="B22-cancers-15-04136" class=" bibr popnode">22</a>,<a href="#B23-cancers-15-04136" rid="B23-cancers-15-04136" class=" bibr popnode">23</a>], or G1-phase arrest in colorectal cancer cells [<a href="#B19-cancers-15-04136" rid="B19-cancers-15-04136" class=" bibr popnode">19</a>]. It seems that phase-specific cell cycle arrest is tumor cell line-specific.</p><p>The accumulation of cells in the G2/M phase may indicate that G2/M mediators are affected by adapalene. Therefore, we studied the impact of adapalene on the microtubule network. Moreover, previous studies demonstrated that c-MYC interacts with &#x003b1;-tubulin and with polymerized microtubules in vitro and in vivo [<a href="#B67-cancers-15-04136" rid="B67-cancers-15-04136" class=" bibr popnode">67</a>]. Microtubules have also been hypothesized to serve as a cytoplasmic repository for c-MYC proteins [<a href="#B68-cancers-15-04136" rid="B68-cancers-15-04136" class=" bibr popnode">68</a>]. Additionally, several drugs that disrupt microtubule dynamics decreased c-MYC expression by reducing the cytoplasmic c-MYC reservoir [<a href="#B69-cancers-15-04136" rid="B69-cancers-15-04136" class=" bibr popnode">69</a>]. Thus, it was fascinating for us to prove whether this reciprocal aspect was true. Microtubules are highly active cytoskeletal structures that are important for many cellular functions such as vesicle transport, cell division, and intracellular organization. Microtubule-targeting agents inhibit the dynamics of microtubules, resulting in a slowdown or blockage of mitosis. This block, which takes place in the G2/M phase, may trigger cell death. Confocal microscopy of adapalene-treated U2OS cells stably expressing &#x003b1;-tubulin-GFP showed an aberrant microtubule arrangement. In fact, adapalene expanded the tubulin mass, surrounding the nucleus while decreasing the growth of microtubules at the borders. Additionally, adapalene-treated cells displayed fragile microtubules at their borders if compared to control cells. To the best of our knowledge, we are the first to decipher that adapalene effectively disrupted the microtubule network, which may account for its cytotoxicity.</p><p>Several authors investigated the essential role of c-MYC in DNA damage signaling [<a href="#B70-cancers-15-04136" rid="B70-cancers-15-04136" class=" bibr popnode">70</a>]. Responses to intracellular stress signals as DNA damage resulted in decreased c-MYC levels due to proteasomal degradation [<a href="#B71-cancers-15-04136" rid="B71-cancers-15-04136" class=" bibr popnode">71</a>]. Moreover, DNA damaging agents (e.g., topoisomerase II inhibitors) or ionizing radiation induced DNA damage as well as c-MYC inhibition in MCF-7 breast cancer cells [<a href="#B72-cancers-15-04136" rid="B72-cancers-15-04136" class=" bibr popnode">72</a>,<a href="#B73-cancers-15-04136" rid="B73-cancers-15-04136" class=" bibr popnode">73</a>]. Furthermore, the knockdown of c-MYC in HeLa-630 cells limited their capacity to repair double-strand breaks following ionizing irradiation [<a href="#B74-cancers-15-04136" rid="B74-cancers-15-04136" class=" bibr popnode">74</a>]. Based on the crucial role of c-MYC in DNA damage repair, studies have demonstrated a relationship between c-MYC and &#x003b3;H2AX. Phosphorylated c-MYC displayed a strong co-localization with &#x003b3;H2AX and the phosphorylated DNA-dependent protein kinase, catalytic subunit at the corresponding S2056 cluster. Consequently, the inhibition of c-MYC resulted in double-strand breaks and an increase in &#x003b3;H2AX [<a href="#B74-cancers-15-04136" rid="B74-cancers-15-04136" class=" bibr popnode">74</a>]. Taking into consideration this relationship between c-MYC and &#x003b3;H2AX, we investigated the effect of adapalene on the protein expression level of &#x003b3;H2AX. Intriguingly, adapalene treatment resulted in a dose-dependent increase in &#x003b3;H2AX, suggesting that the ability of adapalene to inhibit MM growth may be due to its capability to induce DNA damage. Our results were in line with other studies, showing that adapalene induced apoptosis through DNA damage in melanoma cells [<a href="#B20-cancers-15-04136" rid="B20-cancers-15-04136" class=" bibr popnode">20</a>]. It also reduced the growth of prostate cancer cells by triggering DNA damage [<a href="#B22-cancers-15-04136" rid="B22-cancers-15-04136" class=" bibr popnode">22</a>].</p><p>An eminent function of c-MYC is its ability to sensitize cells to apoptosis. Dysregulated c-MYC expression accompanied by anti-proliferative signals initiates apoptosis [<a href="#B75-cancers-15-04136" rid="B75-cancers-15-04136" class=" bibr popnode">75</a>]. Therefore, we examined whether adapalene-mediated cytotoxicity in AMO1 cells was associated with apoptosis. Our results revealed that adapalene induced both early and late apoptosis. Our findings concurred with those of another study showing that the suppression of c-MYC by CPI-0610, a small-molecule bromodomain and extra-terminal protein inhibitor, induced G0/G1 arrest as well as apoptosis in MM, leading to cancer regression [<a href="#B76-cancers-15-04136" rid="B76-cancers-15-04136" class=" bibr popnode">76</a>]. In addition, adapalene promoted apoptosis in triple-negative breast cancer cells, melanoma cells, colorectal cancer cells, bladder cancer cells, hepatoma cells, prostate cancer cell, and ovarian cancer cell [<a href="#B17-cancers-15-04136" rid="B17-cancers-15-04136" class=" bibr popnode">17</a>,<a href="#B20-cancers-15-04136" rid="B20-cancers-15-04136" class=" bibr popnode">20</a>,<a href="#B21-cancers-15-04136" rid="B21-cancers-15-04136" class=" bibr popnode">21</a>,<a href="#B22-cancers-15-04136" rid="B22-cancers-15-04136" class=" bibr popnode">22</a>,<a href="#B23-cancers-15-04136" rid="B23-cancers-15-04136" class=" bibr popnode">23</a>,<a href="#B77-cancers-15-04136" rid="B77-cancers-15-04136" class=" bibr popnode">77</a>,<a href="#B78-cancers-15-04136" rid="B78-cancers-15-04136" class=" bibr popnode">78</a>]. To the best of our knowledge, we are the first to demonstrate that adapalene-mediated c-MYC inhibition induced apoptosis in MM.</p><p>Autophagy is a vital catabolic cellular process in which deteriorated organelles, misfolded proteins, and cellular components are digested and recycled by lysosomes. Autophagy is essential for maintaining cellular homeostasis and allowing cells to adjust to harsh conditions. Additionally, it controls both cell survival and death [<a href="#B79-cancers-15-04136" rid="B79-cancers-15-04136" class=" bibr popnode">79</a>]. The microtubule-associated protein light chain 3 (LC3) and Beclin 1 play essential roles in autophagy. Beclin 1 is a member of the phosphatidylinositol 3-kinase complex (PI3K) type III and is necessary for autophagic vesicle formation. LC3 is activated by a ubiquitination-like reaction mediated by Atg3 and Atg7. Initially, LC3 is cleaved into cytosolic LC3-I which is further changed into a membrane-bound form LC3-II. LC3-II is then attracted to autophagosomes. Therefore, it is considered a special autophagy marker [<a href="#B80-cancers-15-04136" rid="B80-cancers-15-04136" class=" bibr popnode">80</a>]. To decipher whether adapalene triggers autophagy in AMO1 cells, we studied the protein expression level of LC3 and Beclin 1. The fact that LC3-II and Beclin 1 were both upregulated upon adapalene treatment approved that the latter induced autophagy in AMO1 cells. Those findings were further confirmed by an autophagy assay. As far as we know, no previous studies reported the ability of adapalene to trigger autophagy. Several groups demonstrated the interplay between c-MYC and the regulation of autophagy. For instance, 4-O-methyl-ascochlorin inhibited c-MYC and triggered autophagy in leukemic cells [<a href="#B81-cancers-15-04136" rid="B81-cancers-15-04136" class=" bibr popnode">81</a>]. The inhibition of c-MYC by 10058-F4 led to the downregulation of miR-150 and restored the miR-150-mediated autophagy defect in NSCLC [<a href="#B82-cancers-15-04136" rid="B82-cancers-15-04136" class=" bibr popnode">82</a>]. Our findings might also indicate that the induction of autophagy could be accredited to c-MYC inhibition. Surprisingly, the expression of Beclin 1 and LC3-II dropped off at high concentrations (2 &#x000d7; IC<sub>50</sub>). This could be explained by a shift to another cell death as apoptosis. These observations were not detected in the autophagy assay as western blot is more sensitive and detects even minimal changes in protein expression. Numerous reports proved that Beclin 1 is a caspase 3 substrate. Upon caspase 3 activation, Beclin 1 is cleaved and becomes unable to induce autophagy. However, the C-terminal fragment (Beclin 1-C) may relocate to the mitochondria and make cells more susceptible to apoptosis [<a href="#B83-cancers-15-04136" rid="B83-cancers-15-04136" class=" bibr popnode">83</a>]. A reduction of Beclin 1 prompted CED-3/caspase-dependent programmed cell death in <em>C. elegans</em> [<a href="#B84-cancers-15-04136" rid="B84-cancers-15-04136" class=" bibr popnode">84</a>]. Moreover, it has been suggested that LC3 can act as a promoter of apoptosis [<a href="#B83-cancers-15-04136" rid="B83-cancers-15-04136" class=" bibr popnode">83</a>].</p><p>Several authors verified adapalene&#x02019;s in vivo anti-tumor activity in mice [<a href="#B19-cancers-15-04136" rid="B19-cancers-15-04136" class=" bibr popnode">19</a>,<a href="#B22-cancers-15-04136" rid="B22-cancers-15-04136" class=" bibr popnode">22</a>]. Recently, the zebrafish model proved to be an effective in vivo model for both drug development and toxicity evaluation [<a href="#B85-cancers-15-04136" rid="B85-cancers-15-04136" class=" bibr popnode">85</a>]. In the current investigation, we demonstrated that adapalene inhibited tumor growth in vivo by utilizing a CCRF-CEM xenograft tumor zebrafish model.</p><p class="p p-last">One of the study&#x02019;s shortcomings is the inability to examine the impact of adapalene on PBMCs derived from patients with hematological malignancies. In addition, a crucial tool for clinical translation is the analysis of adapalene in murine models of human MM. Therefore, we strive to select the appropriate MM murine model for specific pre-clinical research.</p></div><div id="sec5-cancers-15-04136" class="tsec sec"><h2 class="head no_bottom_margin" id="sec5-cancers-15-04136title">5. Conclusions</h2><p class="p p-first-last">In conclusion, the knowledge gained from this work points to the potential of the third-generation retinoid adapalene to significantly suppress tumor growth via autophagic and apoptotic cell death. Furthermore, adapalene possesses a potent cytotoxic activity through c-MYC inhibition, tubulin network suppression, and DNA damage. The discovery of adapalene as a c-MYC inhibitor may significantly lower the drug development costs of new anticancer medications, providing further insights in the future of adapalene-based designs that could result in more effective and targeted innovative therapies for MM.</p></div><div id="ack-a.s.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.s.atitle">Acknowledgments</h2><div class="sec"><p>We gratefully acknowledge the stipend of the Sibylle Kalkhof-Rose-Foundation to J.C.B.</p></div></div><div id="app1-cancers-15-04136" class="tsec sec"><h2 class="head no_bottom_margin" id="app1-cancers-15-04136title">Supplementary Materials</h2><!--/article/back/app-group/app/--><p>The following supporting information can be downloaded at: <a href="https://www.mdpi.com/article/10.3390/cancers15164136/s1">https://www.mdpi.com/article/10.3390/cancers15164136/s1</a>, Figures S1&#x02013;S5: Original, uncropped Western blot membrane. Table S1: Binding affinities (kcal/mol) of the top 170 FDA compounds as identified by PyRx; Table S2: An overview of the molecular docking results of the top 117 FDA compounds as determined by AutoDock 4.2.6 tools. </p><div class="sec suppmat" id="cancers-15-04136-s001"><div class="sup-box half_rhythm" id="media-a.s.c.a.c.a"><a href="/pmc/articles/PMC10452460/bin/cancers-15-04136-s001.zip" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(424K, zip)</sup></div></div></div><div id="funding-group-a.q.b.t" class="tsec sec"><h2 class="head no_bottom_margin" id="funding-group-a.q.b.ttitle">Funding Statement</h2><p>This research was funded by a private donation of Marc Strobel, Frankfurt, Germany.</p></div><div id="notes-a.s.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.s.dtitle">Author Contributions</h2><p>Conceptualization, J.C.B. and T.E.; methodology, J.C.B.; software, J.C.B.; validation, J.C.B. and L.S.; formal analysis, J.C.B.; investigation, J.C.B.; resources, M.C.; data curation, J.C.B.; writing&#x02014;original draft preparation, J.C.B. and T.E.; writing&#x02014;review and editing, J.C.B. and T.E.; visualization, J.C.B.; supervision, T.E.; project administration, J.C.B.; funding acquisition, J.C.B. All authors have read and agreed to the published version of the manuscript.</p></div><div id="notes-a.s.e" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.s.etitle">Institutional Review Board Statement</h2><p>The animal study protocol was approved by the Association for Assessment and Accreditation of Laboratory Animal Care International (SYXK 2012-0171).</p></div><div id="notes-a.s.f" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.s.ftitle">Informed Consent Statement</h2><p>Written Informed consent was obtained from all subjects involved in the study.</p></div><div id="notes-a.s.g" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.s.gtitle">Data Availability Statement</h2><p>The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy.</p></div><div id="notes-a.s.h" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.s.htitle">Conflicts of Interest</h2><p>The authors declare that there is no conflict of interest.</p></div><div id="fn-group-a.s.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.s.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.s.b.a"><p class="p p-first-last"><strong>Disclaimer/Publisher&#x02019;s Note:</strong> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></p></div></div><div id="ref-list-a.s.i" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.s.ititle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1-cancers-15-04136">1. <span class="element-citation">Banerjee S., Parasramka M.A., Paruthy S.B.  <span class="ref-journal">Role of Nutraceuticals in Cancer Chemosensitization.</span> Elsevier; Amsterdam, The Netherlands: 2018. Garcinol: Preclinical perspective underpinning chemo-and radiosensitization of cancer; pp. 297–324. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Role+of+Nutraceuticals+in+Cancer+Chemosensitization&amp;author=S.+Banerjee&amp;author=M.A.+Parasramka&amp;author=S.B.+Paruthy&amp;publication_year=2018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2-cancers-15-04136">2. <span class="element-citation">Pinto V., Bergantim R., Caires H.R., Seca H., Guimar&#x000e3;es J.E., Vasconcelos M.H. Multiple myeloma: Available therapies and causes of drug resistance. <span><span class="ref-journal">Cancers. </span>2020;<span class="ref-vol">12</span>:407.  doi: 10.3390/cancers12020407.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7072128/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32050631" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fcancers12020407" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Multiple+myeloma:+Available+therapies+and+causes+of+drug+resistance&amp;author=V.+Pinto&amp;author=R.+Bergantim&amp;author=H.R.+Caires&amp;author=H.+Seca&amp;author=J.E.+Guimar&#x000e3;es&amp;volume=12&amp;publication_year=2020&amp;pages=407&amp;pmid=32050631&amp;doi=10.3390/cancers12020407&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3-cancers-15-04136">3. <span class="element-citation">Van de Donk N.W.C.J., Pawlyn C., Yong K.L. Multiple myeloma. <span><span class="ref-journal">Lancet. </span>2021;<span class="ref-vol">397</span>:410–427. doi: 10.1016/S0140-6736(21)00135-5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33516340" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0140-6736(21)00135-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Multiple+myeloma&amp;author=N.W.C.J.+Van+de+Donk&amp;author=C.+Pawlyn&amp;author=K.L.+Yong&amp;volume=397&amp;publication_year=2021&amp;pages=410-427&amp;pmid=33516340&amp;doi=10.1016/S0140-6736(21)00135-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4-cancers-15-04136">4. <span class="element-citation">Bergsagel P.L., Kuehl W.M. Chromosome translocations in multiple myeloma. <span><span class="ref-journal">Oncogene. </span>2001;<span class="ref-vol">20</span>:5611–5622. doi: 10.1038/sj.onc.1204641.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11607813" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1204641" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Chromosome+translocations+in+multiple+myeloma&amp;author=P.L.+Bergsagel&amp;author=W.M.+Kuehl&amp;volume=20&amp;publication_year=2001&amp;pages=5611-5622&amp;pmid=11607813&amp;doi=10.1038/sj.onc.1204641&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5-cancers-15-04136">5. <span class="element-citation">Anguiano A., Tuchman S.A., Acharya C., Salter K., Gasparetto C., Zhan F., Dhodapkar M., Nevins J., Barlogie B., Shaughnessy J.D., Jr. Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma. <span><span class="ref-journal">J. Clin. Oncol. </span>2009;<span class="ref-vol">27</span>:4197. doi: 10.1200/JCO.2008.19.1916.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4881369/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19636021" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.2008.19.1916" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Oncol.&amp;title=Gene+expression+profiles+of+tumor+biology+provide+a+novel+approach+to+prognosis+and+may+guide+the+selection+of+therapeutic+targets+in+multiple+myeloma&amp;author=A.+Anguiano&amp;author=S.A.+Tuchman&amp;author=C.+Acharya&amp;author=K.+Salter&amp;author=C.+Gasparetto&amp;volume=27&amp;publication_year=2009&amp;pages=4197&amp;pmid=19636021&amp;doi=10.1200/JCO.2008.19.1916&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6-cancers-15-04136">6. <span class="element-citation">Holien T., Misund K., Olsen O.E., Baranowska K.A., Buene G., B&#x000f8;rset M., Waage A., Sundan A. Myc amplifications in myeloma cell lines: Correlation with myc-inhibitor efficacy. <span><span class="ref-journal">Oncotarget. </span>2015;<span class="ref-vol">6</span>:22698. doi: 10.18632/oncotarget.4245.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4673192/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26087190" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.4245" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Myc+amplifications+in+myeloma+cell+lines:+Correlation+with+myc-inhibitor+efficacy&amp;author=T.+Holien&amp;author=K.+Misund&amp;author=O.E.+Olsen&amp;author=K.A.+Baranowska&amp;author=G.+Buene&amp;volume=6&amp;publication_year=2015&amp;pages=22698&amp;pmid=26087190&amp;doi=10.18632/oncotarget.4245&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7-cancers-15-04136">7. <span class="element-citation">Affer M., Chesi M., Chen W.D., Keats J.J., Demchenko Y.N., Tamizhmani K., Garbitt V.M., Riggs D.L., Brents L.A., Roschke A.V. Promiscuous myc locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate myc expression in multiple myeloma. <span><span class="ref-journal">Leukemia. </span>2014;<span class="ref-vol">28</span>:1725–1735. doi: 10.1038/leu.2014.70.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4126852/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24518206" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fleu.2014.70" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Promiscuous+myc+locus+rearrangements+hijack+enhancers+but+mostly+super-enhancers+to+dysregulate+myc+expression+in+multiple+myeloma&amp;author=M.+Affer&amp;author=M.+Chesi&amp;author=W.D.+Chen&amp;author=J.J.+Keats&amp;author=Y.N.+Demchenko&amp;volume=28&amp;publication_year=2014&amp;pages=1725-1735&amp;pmid=24518206&amp;doi=10.1038/leu.2014.70&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8-cancers-15-04136">8. <span class="element-citation">Chng W.J., Huang G.F., Chung T.H., Ng S.B., Gonzalez-Paz N., Troska-Price T., Mulligan G., Chesi M., Bergsagel P.L., Fonseca R. Clinical and biological implications of myc activation: A common difference between mgus and newly diagnosed multiple myeloma. <span><span class="ref-journal">Leukemia. </span>2011;<span class="ref-vol">25</span>:1026–1035. doi: 10.1038/leu.2011.53.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3432644/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21468039" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fleu.2011.53" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Clinical+and+biological+implications+of+myc+activation:+A+common+difference+between+mgus+and+newly+diagnosed+multiple+myeloma&amp;author=W.J.+Chng&amp;author=G.F.+Huang&amp;author=T.H.+Chung&amp;author=S.B.+Ng&amp;author=N.+Gonzalez-Paz&amp;volume=25&amp;publication_year=2011&amp;pages=1026-1035&amp;pmid=21468039&amp;doi=10.1038/leu.2011.53&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9-cancers-15-04136">9. <span class="element-citation">Holien T., V&#x000e5;tsveen T.K., Hella H., Rampa C., Brede G., Gr&#x000f8;seth L.A.G., Rekvig M., B&#x000f8;rset M., Standal T., Waage A. Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by smad-dependent repression of myc. <span><span class="ref-journal">Leukemia. </span>2012;<span class="ref-vol">26</span>:1073–1080. doi: 10.1038/leu.2011.263.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21941367" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fleu.2011.263" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Bone+morphogenetic+proteins+induce+apoptosis+in+multiple+myeloma+cells+by+smad-dependent+repression+of+myc&amp;author=T.+Holien&amp;author=T.K.+V&#x000e5;tsveen&amp;author=H.+Hella&amp;author=C.+Rampa&amp;author=G.+Brede&amp;volume=26&amp;publication_year=2012&amp;pages=1073-1080&amp;pmid=21941367&amp;doi=10.1038/leu.2011.263&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10-cancers-15-04136">10. <span class="element-citation">Kang B., Park H., Kim B. Anticancer activity and underlying mechanism of phytochemicals against multiple myeloma. <span><span class="ref-journal">Int. J. Mol. Sci. </span>2019;<span class="ref-vol">20</span>:2302.  doi: 10.3390/ijms20092302.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6539572/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31075954" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fijms20092302" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=Anticancer+activity+and+underlying+mechanism+of+phytochemicals+against+multiple+myeloma&amp;author=B.+Kang&amp;author=H.+Park&amp;author=B.+Kim&amp;volume=20&amp;publication_year=2019&amp;pages=2302&amp;pmid=31075954&amp;doi=10.3390/ijms20092302&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11-cancers-15-04136">11. <span class="element-citation">Mart&#x000ed;nez-Mart&#x000ed;n S., Soucek L. Myc inhibitors in multiple myeloma. <span><span class="ref-journal">Cancer Drug Resist. </span>2021;<span class="ref-vol">4</span>:842. doi: 10.20517/cdr.2021.55.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8992455/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35582389" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.20517%2Fcdr.2021.55" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Drug+Resist.&amp;title=Myc+inhibitors+in+multiple+myeloma&amp;author=S.+Mart&#x000ed;nez-Mart&#x000ed;n&amp;author=L.+Soucek&amp;volume=4&amp;publication_year=2021&amp;pages=842&amp;pmid=35582389&amp;doi=10.20517/cdr.2021.55&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12-cancers-15-04136">12. <span class="element-citation">Wang C., Zhang J., Yin J., Gan Y., Xu S., Gu Y., Huang W. Alternative approaches to target myc for cancer treatment. <span><span class="ref-journal">Signal Transduct. Target. Ther. </span>2021;<span class="ref-vol">6</span>:117. doi: 10.1038/s41392-021-00500-y.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7946937/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33692331" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41392-021-00500-y" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Signal+Transduct.+Target.+Ther.&amp;title=Alternative+approaches+to+target+myc+for+cancer+treatment&amp;author=C.+Wang&amp;author=J.+Zhang&amp;author=J.+Yin&amp;author=Y.+Gan&amp;author=S.+Xu&amp;volume=6&amp;publication_year=2021&amp;pages=117&amp;pmid=33692331&amp;doi=10.1038/s41392-021-00500-y&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13-cancers-15-04136">13. <span class="element-citation">Cao Y., Shan H., Liu M., Liu J., Zhang Z., Xu X., Liu Y., Xu H., Lei H., Yu M. Directly targeting c-myc contributes to the anti-multiple myeloma effect of anlotinib. <span><span class="ref-journal">Cell Death Dis. </span>2021;<span class="ref-vol">12</span>:396. doi: 10.1038/s41419-021-03685-w.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8046985/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33854043" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41419-021-03685-w" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis.&amp;title=Directly+targeting+c-myc+contributes+to+the+anti-multiple+myeloma+effect+of+anlotinib&amp;author=Y.+Cao&amp;author=H.+Shan&amp;author=M.+Liu&amp;author=J.+Liu&amp;author=Z.+Zhang&amp;volume=12&amp;publication_year=2021&amp;pages=396&amp;pmid=33854043&amp;doi=10.1038/s41419-021-03685-w&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14-cancers-15-04136">14. <span class="element-citation">Pushpakom S., Iorio F., Eyers P.A., Escott K.J., Hopper S., Wells A., Doig A., Guilliams T., Latimer J., McNamee C. Drug repurposing: Progress, challenges and recommendations. <span><span class="ref-journal">Nat. Rev. Drug Discov. </span>2019;<span class="ref-vol">18</span>:41–58. doi: 10.1038/nrd.2018.168.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30310233" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrd.2018.168" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Drug+Discov.&amp;title=Drug+repurposing:+Progress,+challenges+and+recommendations&amp;author=S.+Pushpakom&amp;author=F.+Iorio&amp;author=P.A.+Eyers&amp;author=K.J.+Escott&amp;author=S.+Hopper&amp;volume=18&amp;publication_year=2019&amp;pages=41-58&amp;pmid=30310233&amp;doi=10.1038/nrd.2018.168&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15-cancers-15-04136">15. <span class="element-citation">Boulos J.C., Saeed M.E.M., Chatterjee M., B&#x000fc;lb&#x000fc;l Y., Crudo F., Marko D., Munder M., Klauck S.M., Efferth T. Repurposing of the alk inhibitor crizotinib for acute leukemia and multiple myeloma cells. <span><span class="ref-journal">Pharmaceuticals. </span>2021;<span class="ref-vol">14</span>:1126.  doi: 10.3390/ph14111126.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8617756/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34832908" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fph14111126" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Repurposing+of+the+alk+inhibitor+crizotinib+for+acute+leukemia+and+multiple+myeloma+cells&amp;author=J.C.+Boulos&amp;author=M.E.M.+Saeed&amp;author=M.+Chatterjee&amp;author=Y.+B&#x000fc;lb&#x000fc;l&amp;author=F.+Crudo&amp;volume=14&amp;publication_year=2021&amp;pages=1126&amp;pmid=34832908&amp;doi=10.3390/ph14111126&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16-cancers-15-04136">16. <span class="element-citation">Tolaymat L., Dearborn H., Zito P.M.  <span class="ref-journal">StatPearls.</span> StatPearls Publishing; St. Petersburg, FL, USA: 2022. Adapalene. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=StatPearls&amp;author=L.+Tolaymat&amp;author=H.+Dearborn&amp;author=P.M.+Zito&amp;publication_year=2022&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17-cancers-15-04136">17. <span class="element-citation">Ocker M., Herold C., Ganslmayer M., Zopf S., Hahn E.G., Schuppan D. Potentiated anticancer effects on hepatoma cells by the retinoid adapalene. <span><span class="ref-journal">Cancer Lett. </span>2004;<span class="ref-vol">208</span>:51–58. doi: 10.1016/j.canlet.2003.12.026.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15105045" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.canlet.2003.12.026" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett.&amp;title=Potentiated+anticancer+effects+on+hepatoma+cells+by+the+retinoid+adapalene&amp;author=M.+Ocker&amp;author=C.+Herold&amp;author=M.+Ganslmayer&amp;author=S.+Zopf&amp;author=E.G.+Hahn&amp;volume=208&amp;publication_year=2004&amp;pages=51-58&amp;pmid=15105045&amp;doi=10.1016/j.canlet.2003.12.026&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18-cancers-15-04136">18. <span class="element-citation">Rusu A., Tanase C., Pascu G.-A., Todoran N. Recent advances regarding the therapeutic potential of adapalene. <span><span class="ref-journal">Pharmaceuticals. </span>2020;<span class="ref-vol">13</span>:217.  doi: 10.3390/ph13090217.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7558148/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32872149" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fph13090217" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Recent+advances+regarding+the+therapeutic+potential+of+adapalene&amp;author=A.+Rusu&amp;author=C.+Tanase&amp;author=G.-A.+Pascu&amp;author=N.+Todoran&amp;volume=13&amp;publication_year=2020&amp;pages=217&amp;pmid=32872149&amp;doi=10.3390/ph13090217&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19-cancers-15-04136">19. <span class="element-citation">Shi X.N., Li H., Yao H., Liu X., Li L., Leung K.S., Kung H.F., Lin M.C.M. Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma. <span><span class="ref-journal">Mol. Med. Rep. </span>2015;<span class="ref-vol">12</span>:6501–6508. doi: 10.3892/mmr.2015.4310.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4626183/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26398439" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3892%2Fmmr.2015.4310" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Med.+Rep.&amp;title=Adapalene+inhibits+the+activity+of+cyclin-dependent+kinase+2+in+colorectal+carcinoma&amp;author=X.N.+Shi&amp;author=H.+Li&amp;author=H.+Yao&amp;author=X.+Liu&amp;author=L.+Li&amp;volume=12&amp;publication_year=2015&amp;pages=6501-6508&amp;pmid=26398439&amp;doi=10.3892/mmr.2015.4310&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20-cancers-15-04136">20. <span class="element-citation">Li H., Wang C., Li L., Bu W., Zhang M., Wei J., Tao L., Qian K., Ma P. Adapalene suppressed the proliferation of melanoma cells by s-phase arrest and subsequent apoptosis via induction of DNA damage. <span><span class="ref-journal">Eur. J. Pharmacol. </span>2019;<span class="ref-vol">851</span>:174–185. doi: 10.1016/j.ejphar.2019.03.004.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30836068" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ejphar.2019.03.004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Pharmacol.&amp;title=Adapalene+suppressed+the+proliferation+of+melanoma+cells+by+s-phase+arrest+and+subsequent+apoptosis+via+induction+of+DNA+damage&amp;author=H.+Li&amp;author=C.+Wang&amp;author=L.+Li&amp;author=W.+Bu&amp;author=M.+Zhang&amp;volume=851&amp;publication_year=2019&amp;pages=174-185&amp;pmid=30836068&amp;doi=10.1016/j.ejphar.2019.03.004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21-cancers-15-04136">21. <span class="element-citation">Wang Q., Zhang Q., Luan S., Yang K., Zheng M., Li K., Chen L., Li H. Adapalene inhibits ovarian cancer es-2 cells growth by targeting glutamic-oxaloacetic transaminase 1. <span><span class="ref-journal">Bioorg. Chem. </span>2019;<span class="ref-vol">93</span>:103315. doi: 10.1016/j.bioorg.2019.103315.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31605927" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bioorg.2019.103315" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.+Chem.&amp;title=Adapalene+inhibits+ovarian+cancer+es-2+cells+growth+by+targeting+glutamic-oxaloacetic+transaminase+1&amp;author=Q.+Wang&amp;author=Q.+Zhang&amp;author=S.+Luan&amp;author=K.+Yang&amp;author=M.+Zheng&amp;volume=93&amp;publication_year=2019&amp;pages=103315&amp;pmid=31605927&amp;doi=10.1016/j.bioorg.2019.103315&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22-cancers-15-04136">22. <span class="element-citation">Nong H.-B., Zhang Y.-N., Bai Y.-G., Zhang Q., Liu M.-F., Zhou Q., Shi Z.-H., Zeng G.-F., Zong S.-H. Adapalene inhibits prostate cancer cell proliferation in vitro and in vivo by inducing DNA damage, s-phase cell cycle arrest, and apoptosis. <span><span class="ref-journal">Front. Pharmacol. </span>2022;<span class="ref-vol">13</span>:801624. doi: 10.3389/fphar.2022.801624.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8902295/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35273495" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffphar.2022.801624" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Pharmacol.&amp;title=Adapalene+inhibits+prostate+cancer+cell+proliferation+in+vitro+and+in+vivo+by+inducing+DNA+damage,+s-phase+cell+cycle+arrest,+and+apoptosis&amp;author=H.-B.+Nong&amp;author=Y.-N.+Zhang&amp;author=Y.-G.+Bai&amp;author=Q.+Zhang&amp;author=M.-F.+Liu&amp;volume=13&amp;publication_year=2022&amp;pages=801624&amp;pmid=35273495&amp;doi=10.3389/fphar.2022.801624&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23-cancers-15-04136">23. <span class="element-citation">Mehraj U., Wani N.A., Hamid A., Alkhanani M., Almilaibary A., Mir M.A. Adapalene inhibits the growth of triple-negative breast cancer cells by s-phase arrest and potentiates the antitumor efficacy of gdc-0941. <span><span class="ref-journal">Front. Pharmacol. </span>2022;<span class="ref-vol">13</span>:958443. doi: 10.3389/fphar.2022.958443.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9393306/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36003501" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffphar.2022.958443" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Pharmacol.&amp;title=Adapalene+inhibits+the+growth+of+triple-negative+breast+cancer+cells+by+s-phase+arrest+and+potentiates+the+antitumor+efficacy+of+gdc-0941&amp;author=U.+Mehraj&amp;author=N.A.+Wani&amp;author=A.+Hamid&amp;author=M.+Alkhanani&amp;author=A.+Almilaibary&amp;volume=13&amp;publication_year=2022&amp;pages=958443&amp;pmid=36003501&amp;doi=10.3389/fphar.2022.958443&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24-cancers-15-04136">24. <span class="element-citation">Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. <span><span class="ref-journal">Nucleic Acids Res. </span>2000;<span class="ref-vol">28</span>:235–242. doi: 10.1093/nar/28.1.235.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC102472/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10592235" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fnar%2F28.1.235" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res.&amp;title=The+protein+data+bank&amp;author=H.M.+Berman&amp;author=J.+Westbrook&amp;author=Z.+Feng&amp;author=G.+Gilliland&amp;author=T.N.+Bhat&amp;volume=28&amp;publication_year=2000&amp;pages=235-242&amp;pmid=10592235&amp;doi=10.1093/nar/28.1.235&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25-cancers-15-04136">25. <span class="element-citation">Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. Autodock4 and autodocktools4: Automated docking with selective receptor flexibility. <span><span class="ref-journal">J. Comput. Chem. </span>2009;<span class="ref-vol">30</span>:2785–2791. doi: 10.1002/jcc.21256.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2760638/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19399780" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjcc.21256" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Comput.+Chem.&amp;title=Autodock4+and+autodocktools4:+Automated+docking+with+selective+receptor+flexibility&amp;author=G.M.+Morris&amp;author=R.+Huey&amp;author=W.+Lindstrom&amp;author=M.F.+Sanner&amp;author=R.K.+Belew&amp;volume=30&amp;publication_year=2009&amp;pages=2785-2791&amp;pmid=19399780&amp;doi=10.1002/jcc.21256&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26-cancers-15-04136">26. <span class="element-citation">Clausen D.M., Guo J., Parise R.A., Beumer J.H., Egorin M.J., Lazo J.S., Prochownik E.V., Eiseman J.L. In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-g5, a novel small-molecule inhibitor of c-myc/max dimerization. <span><span class="ref-journal">J. Pharmacol. Exp. Ther. </span>2010;<span class="ref-vol">335</span>:715–727. doi: 10.1124/jpet.110.170555.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2993546/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20801893" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fjpet.110.170555" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Pharmacol.+Exp.+Ther.&amp;title=In+vitro+cytotoxicity+and+in+vivo+efficacy,+pharmacokinetics,+and+metabolism+of+10074-g5,+a+novel+small-molecule+inhibitor+of+c-myc/max+dimerization&amp;author=D.M.+Clausen&amp;author=J.+Guo&amp;author=R.A.+Parise&amp;author=J.H.+Beumer&amp;author=M.J.+Egorin&amp;volume=335&amp;publication_year=2010&amp;pages=715-727&amp;pmid=20801893&amp;doi=10.1124/jpet.110.170555&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27-cancers-15-04136">27. <span class="element-citation">Yap J.L., Wang H., Hu A., Chauhan J., Jung K.-Y., Gharavi R.B., Prochownik E.V., Fletcher S. Pharmacophore identification of c-myc inhibitor 10074-g5. <span><span class="ref-journal">Bioorg. Med. Chem. Lett. </span>2013;<span class="ref-vol">23</span>:370–374. doi: 10.1016/j.bmcl.2012.10.013.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3525812/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23177256" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bmcl.2012.10.013" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.+Med.+Chem.+Lett.&amp;title=Pharmacophore+identification+of+c-myc+inhibitor+10074-g5&amp;author=J.L.+Yap&amp;author=H.+Wang&amp;author=A.+Hu&amp;author=J.+Chauhan&amp;author=K.-Y.+Jung&amp;volume=23&amp;publication_year=2013&amp;pages=370-374&amp;pmid=23177256&amp;doi=10.1016/j.bmcl.2012.10.013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28-cancers-15-04136">28. <span class="element-citation">Elbadawi M., Boulos J.C., Dawood M., Zhou M., Gul W., ElSohly M.A., Klauck S.M., Efferth T. The novel artemisinin dimer isoniazide eli-xxiii-98-2 induces c-myc inhibition, DNA damage, and autophagy in leukemia cells. <span><span class="ref-journal">Pharmaceutics. </span>2023;<span class="ref-vol">15</span>:1107.  doi: 10.3390/pharmaceutics15041107.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10144546/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37111592" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fpharmaceutics15041107" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=The+novel+artemisinin+dimer+isoniazide+eli-xxiii-98-2+induces+c-myc+inhibition,+DNA+damage,+and+autophagy+in+leukemia+cells&amp;author=M.+Elbadawi&amp;author=J.C.+Boulos&amp;author=M.+Dawood&amp;author=M.+Zhou&amp;author=W.+Gul&amp;volume=15&amp;publication_year=2023&amp;pages=1107&amp;pmid=37111592&amp;doi=10.3390/pharmaceutics15041107&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29-cancers-15-04136">29. <span class="element-citation">Boulos J.C., Omer E.A., Rigano D., Formisano C., Chatterjee M., Leich E., Klauck S.M., Shan L.-T., Efferth T. Cynaropicrin disrupts tubulin and c-myc-related signaling and induces parthanatos-type cell death in multiple myeloma. <span><span class="ref-journal">Acta Pharmacol. Sin. </span>2023:1–17. doi: 10.1038/s41401-023-01117-3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10618500/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37344563" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41401-023-01117-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Pharmacol.+Sin.&amp;title=Cynaropicrin+disrupts+tubulin+and+c-myc-related+signaling+and+induces+parthanatos-type+cell+death+in+multiple+myeloma&amp;author=J.C.+Boulos&amp;author=E.A.+Omer&amp;author=D.+Rigano&amp;author=C.+Formisano&amp;author=M.+Chatterjee&amp;publication_year=2023&amp;pages=1-17&amp;doi=10.1038/s41401-023-01117-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30-cancers-15-04136">30. <span class="element-citation">Geske L., Baier J., Boulos J.C., Efferth T., Opatz T. Xylochemical synthesis and biological evaluation of the orchidaceous natural products isoarundinin i, bleochrin f, blestanol k, and pleionol. <span><span class="ref-journal">J. Nat. Prod. </span>2022;<span class="ref-vol">86</span>:131–137. doi: 10.1021/acs.jnatprod.2c00830.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36538372" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1021%2Facs.jnatprod.2c00830" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Nat.+Prod.&amp;title=Xylochemical+synthesis+and+biological+evaluation+of+the+orchidaceous+natural+products+isoarundinin+i,+bleochrin+f,+blestanol+k,+and+pleionol&amp;author=L.+Geske&amp;author=J.+Baier&amp;author=J.C.+Boulos&amp;author=T.+Efferth&amp;author=T.+Opatz&amp;volume=86&amp;publication_year=2022&amp;pages=131-137&amp;pmid=36538372&amp;doi=10.1021/acs.jnatprod.2c00830&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31-cancers-15-04136">31. <span class="element-citation">Zhou M., Boulos J.C., Klauck S.M., Efferth T. The cardiac glycoside zinc253504760 induces parthanatos-type cell death and g2/m arrest via downregulation of mek1/2 phosphorylation in leukemia cells. <span><span class="ref-journal">Cell Biol. Toxicol. </span>2023:1–27. doi: 10.1007/s10565-023-09813-w.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10693532/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37322258" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10565-023-09813-w" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Biol.+Toxicol.&amp;title=The+cardiac+glycoside+zinc253504760+induces+parthanatos-type+cell+death+and+g2/m+arrest+via+downregulation+of+mek1/2+phosphorylation+in+leukemia+cells&amp;author=M.+Zhou&amp;author=J.C.+Boulos&amp;author=S.M.+Klauck&amp;author=T.+Efferth&amp;publication_year=2023&amp;pages=1-27&amp;doi=10.1007/s10565-023-09813-w&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32-cancers-15-04136">32. <span class="element-citation">Zhou M., Boulos J.C., Omer E.A., Klauck S.M., Efferth T. Modes of action of a novel c-myc inhibiting 1,2,4-oxadiazole derivative in leukemia and breast cancer cells. <span><span class="ref-journal">Molecules. </span>2023;<span class="ref-vol">28</span>:5658.  doi: 10.3390/molecules28155658.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10419799/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37570631" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fmolecules28155658" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Modes+of+action+of+a+novel+c-myc+inhibiting+1,2,4-oxadiazole+derivative+in+leukemia+and+breast+cancer+cells&amp;author=M.+Zhou&amp;author=J.C.+Boulos&amp;author=E.A.+Omer&amp;author=S.M.+Klauck&amp;author=T.+Efferth&amp;volume=28&amp;publication_year=2023&amp;pages=5658&amp;pmid=37570631&amp;doi=10.3390/molecules28155658&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33-cancers-15-04136">33. <span class="element-citation">Khalid S.A., Dawood M., Boulos J.C., Wasfi M., Drif A., Bahramimehr F., Shahhamzehei N., Shan L., Efferth T. Identification of gedunin from a phytochemical depository as a novel multidrug resistance-bypassing tubulin inhibitor of cancer cells. <span><span class="ref-journal">Molecules. </span>2022;<span class="ref-vol">27</span>:5858.  doi: 10.3390/molecules27185858.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9501561/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36144591" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fmolecules27185858" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Identification+of+gedunin+from+a+phytochemical+depository+as+a+novel+multidrug+resistance-bypassing+tubulin+inhibitor+of+cancer+cells&amp;author=S.A.+Khalid&amp;author=M.+Dawood&amp;author=J.C.+Boulos&amp;author=M.+Wasfi&amp;author=A.+Drif&amp;volume=27&amp;publication_year=2022&amp;pages=5858&amp;pmid=36144591&amp;doi=10.3390/molecules27185858&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34-cancers-15-04136">34. <span class="element-citation">Saeed M.E.M., Boulos J.C., Muecklich S.B., Leich E., Chatterjee M., Klauck S.M., Efferth T. Disruption of lipid raft microdomains, regulation of cd38, tp53, and myc signaling, and induction of apoptosis by lomitapide in multiple myeloma cells. <span><span class="ref-journal">Cancer Genom. Proteom. </span>2022;<span class="ref-vol">19</span>:540–555. doi: 10.21873/cgp.20339.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9353726/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35985681" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.21873%2Fcgp.20339" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Genom.+Proteom.&amp;title=Disruption+of+lipid+raft+microdomains,+regulation+of+cd38,+tp53,+and+myc+signaling,+and+induction+of+apoptosis+by+lomitapide+in+multiple+myeloma+cells&amp;author=M.E.M.+Saeed&amp;author=J.C.+Boulos&amp;author=S.B.+Muecklich&amp;author=E.+Leich&amp;author=M.+Chatterjee&amp;volume=19&amp;publication_year=2022&amp;pages=540-555&amp;pmid=35985681&amp;doi=10.21873/cgp.20339&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35-cancers-15-04136">35. <span class="element-citation">Rykowski S., Gurda-Wo&#x0017a;na D., Orlicka-P&#x00142;ocka M., Fedoruk-Wyszomirska A., Giel-Pietraszuk M., Wyszko E., Kowalczyk A., St&#x00105;czek P., Bak A., Kiliszek A. Design, synthesis, and evaluation of novel 3-carboranyl-1, 8-naphthalimide derivatives as potential anticancer agents. <span><span class="ref-journal">Int. J. Mol. Sci. </span>2021;<span class="ref-vol">22</span>:2772.  doi: 10.3390/ijms22052772.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7967199/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33803403" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fijms22052772" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=Design,+synthesis,+and+evaluation+of+novel+3-carboranyl-1,+8-naphthalimide+derivatives+as+potential+anticancer+agents&amp;author=S.+Rykowski&amp;author=D.+Gurda-Wo&#x0017a;na&amp;author=M.+Orlicka-P&#x00142;ocka&amp;author=A.+Fedoruk-Wyszomirska&amp;author=M.+Giel-Pietraszuk&amp;volume=22&amp;publication_year=2021&amp;pages=2772&amp;pmid=33803403&amp;doi=10.3390/ijms22052772&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36-cancers-15-04136">36. <span class="element-citation">Saeed M.E.M., Boulos J.C., Machel K., Andabili N., Marouni T., Roth W., Efferth T. Expression of the stem cell marker abcb5 in normal and tumor tissues. <span><span class="ref-journal">In Vivo. </span>2022;<span class="ref-vol">36</span>:1651–1666. doi: 10.21873/invivo.12877.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9301431/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35738589" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.21873%2Finvivo.12877" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=In+Vivo&amp;title=Expression+of+the+stem+cell+marker+abcb5+in+normal+and+tumor+tissues&amp;author=M.E.M.+Saeed&amp;author=J.C.+Boulos&amp;author=K.+Machel&amp;author=N.+Andabili&amp;author=T.+Marouni&amp;volume=36&amp;publication_year=2022&amp;pages=1651-1666&amp;pmid=35738589&amp;doi=10.21873/invivo.12877&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37-cancers-15-04136">37. <span class="element-citation">Lu X., Yan G., Klauck S.M., Fleischer E., Klinger A., Sugimoto Y., Shan L., Efferth T. Cytotoxicity of 4-hydroxy-n-(naphthalen-1-yl)-2-oxo-2h-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of perk/eif2&#x003b1;/atf4 pathway. <span><span class="ref-journal">Biochem. Pharmacol. </span>2021;<span class="ref-vol">193</span>:114788. doi: 10.1016/j.bcp.2021.114788.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34582772" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bcp.2021.114788" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+Pharmacol.&amp;title=Cytotoxicity+of+4-hydroxy-n-(naphthalen-1-yl)-2-oxo-2h-chromene-3-carboxamide+in+multidrug-resistant+cancer+cells+through+activation+of+perk/eif2&#x003b1;/atf4+pathway&amp;author=X.+Lu&amp;author=G.+Yan&amp;author=S.M.+Klauck&amp;author=E.+Fleischer&amp;author=A.+Klinger&amp;volume=193&amp;publication_year=2021&amp;pages=114788&amp;pmid=34582772&amp;doi=10.1016/j.bcp.2021.114788&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38-cancers-15-04136">38. <span class="element-citation">Neves B.J., Braga R.C., Melo-Filho C.C., Moreira-Filho J.T., Muratov E.N., Andrade C.H. Qsar-based virtual screening: Advances and applications in drug discovery. <span><span class="ref-journal">Front. Pharmacol. </span>2018;<span class="ref-vol">9</span>:1275. doi: 10.3389/fphar.2018.01275.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6262347/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30524275" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffphar.2018.01275" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Pharmacol.&amp;title=Qsar-based+virtual+screening:+Advances+and+applications+in+drug+discovery&amp;author=B.J.+Neves&amp;author=R.C.+Braga&amp;author=C.C.+Melo-Filho&amp;author=J.T.+Moreira-Filho&amp;author=E.N.+Muratov&amp;volume=9&amp;publication_year=2018&amp;pages=1275&amp;pmid=30524275&amp;doi=10.3389/fphar.2018.01275&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39-cancers-15-04136">39. <span class="element-citation">Holien T., V&#x000e5;tsveen T.K., Hella H., Waage A., Sundan A. Addiction to c-myc in multiple myeloma. <span><span class="ref-journal">Blood J. Am. Soc. Hematol. </span>2012;<span class="ref-vol">120</span>:2450–2453. doi: 10.1182/blood-2011-08-371567.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22806891" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2011-08-371567" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood+J.+Am.+Soc.+Hematol.&amp;title=Addiction+to+c-myc+in+multiple+myeloma&amp;author=T.+Holien&amp;author=T.K.+V&#x000e5;tsveen&amp;author=H.+Hella&amp;author=A.+Waage&amp;author=A.+Sundan&amp;volume=120&amp;publication_year=2012&amp;pages=2450-2453&amp;doi=10.1182/blood-2011-08-371567&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40-cancers-15-04136">40. <span class="element-citation">Wienken C.J., Baaske P., Rothbauer U., Braun D., Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. <span><span class="ref-journal">Nat. Commun. </span>2010;<span class="ref-vol">1</span>:100. doi: 10.1038/ncomms1093.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20981028" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fncomms1093" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Commun.&amp;title=Protein-binding+assays+in+biological+liquids+using+microscale+thermophoresis&amp;author=C.J.+Wienken&amp;author=P.+Baaske&amp;author=U.+Rothbauer&amp;author=D.+Braun&amp;author=S.+Duhr&amp;volume=1&amp;publication_year=2010&amp;pages=100&amp;pmid=20981028&amp;doi=10.1038/ncomms1093&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41-cancers-15-04136">41. <span class="element-citation">Delmore J.E., Issa G.C., Lemieux M.E., Rahl P.B., Shi J., Jacobs H.M., Kastritis E., Gilpatrick T., Paranal R.M., Qi J. Bet bromodomain inhibition as a therapeutic strategy to target c-myc. <span><span class="ref-journal">Cell. </span>2011;<span class="ref-vol">146</span>:904–917. doi: 10.1016/j.cell.2011.08.017.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3187920/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21889194" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cell.2011.08.017" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Bet+bromodomain+inhibition+as+a+therapeutic+strategy+to+target+c-myc&amp;author=J.E.+Delmore&amp;author=G.C.+Issa&amp;author=M.E.+Lemieux&amp;author=P.B.+Rahl&amp;author=J.+Shi&amp;volume=146&amp;publication_year=2011&amp;pages=904-917&amp;pmid=21889194&amp;doi=10.1016/j.cell.2011.08.017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42-cancers-15-04136">42. <span class="element-citation">Ozawa K. Reduction of phosphorylated histone h3 serine 10 and serine 28 cell cycle marker intensities after DNA damage. <span><span class="ref-journal">Cytom. Part A J. Int. Soc. Anal. Cytol. </span>2008;<span class="ref-vol">73</span>:517–527. doi: 10.1002/cyto.a.20559.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18395832" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fcyto.a.20559" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cytom.+Part+A+J.+Int.+Soc.+Anal.+Cytol.&amp;title=Reduction+of+phosphorylated+histone+h3+serine+10+and+serine+28+cell+cycle+marker+intensities+after+DNA+damage&amp;author=K.+Ozawa&amp;volume=73&amp;publication_year=2008&amp;pages=517-527&amp;doi=10.1002/cyto.a.20559&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43-cancers-15-04136">43. <span class="element-citation">Park C., Cha H.-J., Lee H., Hwang-Bo H., Ji S.Y., Kim M.Y., Hong S.H., Jeong J.-W., Han M.H., Choi S.H. Induction of g2/m cell cycle arrest and apoptosis by genistein in human bladder cancer t24 cells through inhibition of the ros-dependent pi3k/akt signal transduction pathway. <span><span class="ref-journal">Antioxidants. </span>2019;<span class="ref-vol">8</span>:327.  doi: 10.3390/antiox8090327.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6769882/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31438633" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fantiox8090327" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antioxidants&amp;title=Induction+of+g2/m+cell+cycle+arrest+and+apoptosis+by+genistein+in+human+bladder+cancer+t24+cells+through+inhibition+of+the+ros-dependent+pi3k/akt+signal+transduction+pathway&amp;author=C.+Park&amp;author=H.-J.+Cha&amp;author=H.+Lee&amp;author=H.+Hwang-Bo&amp;author=S.Y.+Ji&amp;volume=8&amp;publication_year=2019&amp;pages=327&amp;pmid=31438633&amp;doi=10.3390/antiox8090327&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44-cancers-15-04136">44. <span class="element-citation">Nagai Y., Mimura N., Rizq O., Isshiki Y., Oshima M., Rizk M., Saraya A., Koide S., Nakajima-Takagi Y., Miyota M. The combination of the tubulin binding small molecule ptc596 and proteasome inhibitors suppresses the growth of myeloma cells. <span><span class="ref-journal">Sci. Rep. </span>2021;<span class="ref-vol">11</span>:2074. doi: 10.1038/s41598-021-81577-x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7822878/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33483574" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-021-81577-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=The+combination+of+the+tubulin+binding+small+molecule+ptc596+and+proteasome+inhibitors+suppresses+the+growth+of+myeloma+cells&amp;author=Y.+Nagai&amp;author=N.+Mimura&amp;author=O.+Rizq&amp;author=Y.+Isshiki&amp;author=M.+Oshima&amp;volume=11&amp;publication_year=2021&amp;pages=2074&amp;pmid=33483574&amp;doi=10.1038/s41598-021-81577-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45-cancers-15-04136">45. <span class="element-citation">Rashan L.J., &#x000d6;zenver N., Boulos J.C., Dawood M., Roos W.P., Franke K., Papasotiriou I., Wessjohann L.A., Fiebig H.-H., Efferth T. Molecular modes of action of an aqueous nerium oleander extract in cancer cells in vitro and in vivo. <span><span class="ref-journal">Molecules. </span>2023;<span class="ref-vol">28</span>:1871.  doi: 10.3390/molecules28041871.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9960564/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36838857" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fmolecules28041871" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Molecular+modes+of+action+of+an+aqueous+nerium+oleander+extract+in+cancer+cells+in+vitro+and+in+vivo&amp;author=L.J.+Rashan&amp;author=N.+&#x000d6;zenver&amp;author=J.C.+Boulos&amp;author=M.+Dawood&amp;author=W.P.+Roos&amp;volume=28&amp;publication_year=2023&amp;pages=1871&amp;pmid=36838857&amp;doi=10.3390/molecules28041871&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46-cancers-15-04136">46. <span class="element-citation">Noguchi M., Hirata N., Tanaka T., Suizu F., Nakajima H., Chiorini J.A. Autophagy as a modulator of cell death machinery. <span><span class="ref-journal">Cell Death Dis. </span>2020;<span class="ref-vol">11</span>:517. doi: 10.1038/s41419-020-2724-5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7343815/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32641772" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41419-020-2724-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis.&amp;title=Autophagy+as+a+modulator+of+cell+death+machinery&amp;author=M.+Noguchi&amp;author=N.+Hirata&amp;author=T.+Tanaka&amp;author=F.+Suizu&amp;author=H.+Nakajima&amp;volume=11&amp;publication_year=2020&amp;pages=517&amp;pmid=32641772&amp;doi=10.1038/s41419-020-2724-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47-cancers-15-04136">47. <span class="element-citation">Li Z., Owonikoko T.K., Sun S.-Y., Ramalingam S.S., Doetsch P.W., Xiao Z.-Q., Khuri F.R., Curran W.J., Deng X. C-myc suppression of DNA double-strand break repair. <span><span class="ref-journal">Neoplasia. </span>2012;<span class="ref-vol">14</span>:1190&#x02013;1202, IN32&#x02013;IN35. doi: 10.1593/neo.121258.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3540944/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23308051" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1593%2Fneo.121258" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia&amp;title=C-myc+suppression+of+DNA+double-strand+break+repair&amp;author=Z.+Li&amp;author=T.K.+Owonikoko&amp;author=S.-Y.+Sun&amp;author=S.S.+Ramalingam&amp;author=P.W.+Doetsch&amp;volume=14&amp;publication_year=2012&amp;pages=1190-1202&amp;pmid=23308051&amp;doi=10.1593/neo.121258&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48-cancers-15-04136">48. <span class="element-citation">Valdiglesias V., Giunta S., Fenech M., Neri M., Bonassi S. &#x00393;h2ax as a marker of DNA double strand breaks and genomic instability in human population studies. <span><span class="ref-journal">Mutat. Res./Rev. Mutat. Res. </span>2013;<span class="ref-vol">753</span>:24–40. doi: 10.1016/j.mrrev.2013.02.001.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23416207" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.mrrev.2013.02.001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mutat.+Res./Rev.+Mutat.+Res.&amp;title=&#x00393;h2ax+as+a+marker+of+DNA+double+strand+breaks+and+genomic+instability+in+human+population+studies&amp;author=V.+Valdiglesias&amp;author=S.+Giunta&amp;author=M.+Fenech&amp;author=M.+Neri&amp;author=S.+Bonassi&amp;volume=753&amp;publication_year=2013&amp;pages=24-40&amp;pmid=23416207&amp;doi=10.1016/j.mrrev.2013.02.001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49-cancers-15-04136">49. <span class="element-citation">Sacchi S., Russo D., Avvisati G., Dastoli G., Lazzarino M., Pelicci P.G., Bonora M.R., Visani G., Grassi C., Iacona I. All-trans retinoic acid in hematological malignancies, an update. Ger (gruppo ematologico retinoidi) <span><span class="ref-journal">Haematologica. </span>1997;<span class="ref-vol">82</span>:106–121.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9107096" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=All-trans+retinoic+acid+in+hematological+malignancies,+an+update.+Ger+(gruppo+ematologico+retinoidi)&amp;author=S.+Sacchi&amp;author=D.+Russo&amp;author=G.+Avvisati&amp;author=G.+Dastoli&amp;author=M.+Lazzarino&amp;volume=82&amp;publication_year=1997&amp;pages=106-121&amp;pmid=9107096&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50-cancers-15-04136">50. <span class="element-citation">Chen S., Hu Q., Tao X., Xia J., Wu T., Cheng B., Wang J. Retinoids in cancer chemoprevention and therapy: Meta-analysis of randomized controlled trials. <span><span class="ref-journal">Front. Genet. </span>2022;<span class="ref-vol">13</span>:1065320. doi: 10.3389/fgene.2022.1065320.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9681997/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36437918" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffgene.2022.1065320" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Genet.&amp;title=Retinoids+in+cancer+chemoprevention+and+therapy:+Meta-analysis+of+randomized+controlled+trials&amp;author=S.+Chen&amp;author=Q.+Hu&amp;author=X.+Tao&amp;author=J.+Xia&amp;author=T.+Wu&amp;volume=13&amp;publication_year=2022&amp;pages=1065320&amp;pmid=36437918&amp;doi=10.3389/fgene.2022.1065320&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B51-cancers-15-04136">51. <span class="element-citation">Jin Y., Teh S.S., Lau H.L.N., Xiao J., Mah S.H. Retinoids as anti-cancer agents and their mechanisms of action. <span><span class="ref-journal">Am. J. Cancer Res. </span>2022;<span class="ref-vol">12</span>:938.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8984900/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35411232" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Cancer+Res.&amp;title=Retinoids+as+anti-cancer+agents+and+their+mechanisms+of+action&amp;author=Y.+Jin&amp;author=S.S.+Teh&amp;author=H.L.N.+Lau&amp;author=J.+Xiao&amp;author=S.H.+Mah&amp;volume=12&amp;publication_year=2022&amp;pages=938&amp;pmid=35411232&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B52-cancers-15-04136">52. <span class="element-citation">Tang X.-H., Gudas L.J. Retinoids, retinoic acid receptors, and cancer. <span><span class="ref-journal">Annu. Rev. Pathol. Mech. Dis. </span>2011;<span class="ref-vol">6</span>:345–364. doi: 10.1146/annurev-pathol-011110-130303.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21073338" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev-pathol-011110-130303" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu.+Rev.+Pathol.+Mech.+Dis.&amp;title=Retinoids,+retinoic+acid+receptors,+and+cancer&amp;author=X.-H.+Tang&amp;author=L.J.+Gudas&amp;volume=6&amp;publication_year=2011&amp;pages=345-364&amp;doi=10.1146/annurev-pathol-011110-130303&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B53-cancers-15-04136">53. <span class="element-citation">Ni X., Hu G., Cai X. The success and the challenge of all-trans retinoic acid in the treatment of cancer. <span><span class="ref-journal">Crit. Rev. Food Sci. Nutr. </span>2019;<span class="ref-vol">59</span>:S71–S80. doi: 10.1080/10408398.2018.1509201.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30277803" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F10408398.2018.1509201" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit.+Rev.+Food+Sci.+Nutr.&amp;title=The+success+and+the+challenge+of+all-trans+retinoic+acid+in+the+treatment+of+cancer&amp;author=X.+Ni&amp;author=G.+Hu&amp;author=X.+Cai&amp;volume=59&amp;publication_year=2019&amp;pages=S71-S80&amp;pmid=30277803&amp;doi=10.1080/10408398.2018.1509201&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B54-cancers-15-04136">54. <span class="element-citation">Cunliffe W.J., Caputo R., Dreno B., F&#x000f6;rstr&#x000f6;m L., Heenen M., Orfanos C.E., Privat Y., Aguilar A.R., Poncet M., Verschoore M. Efficacy and safety comparison of adapalene (cd271) gel and tretinoin gel in the topical treatment of acne vulgaris. A european multicentre trial. <span><span class="ref-journal">J. Dermatol. Treat. </span>1997;<span class="ref-vol">8</span>:173–178. doi: 10.3109/09546639709160514.</span> [<a href="//doi.org/10.3109%2F09546639709160514" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Dermatol.+Treat.&amp;title=Efficacy+and+safety+comparison+of+adapalene+(cd271)+gel+and+tretinoin+gel+in+the+topical+treatment+of+acne+vulgaris.+A+european+multicentre+trial&amp;author=W.J.+Cunliffe&amp;author=R.+Caputo&amp;author=B.+Dreno&amp;author=L.+F&#x000f6;rstr&#x000f6;m&amp;author=M.+Heenen&amp;volume=8&amp;publication_year=1997&amp;pages=173-178&amp;doi=10.3109/09546639709160514&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B55-cancers-15-04136">55. <span class="element-citation">Boulos J.C., Idres M.R.Y., Efferth T. Investigation of cancer drug resistance mechanisms by phosphoproteomics. <span><span class="ref-journal">Pharmacol. Res. </span>2020;<span class="ref-vol">160</span>:105091. doi: 10.1016/j.phrs.2020.105091.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32712320" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.phrs.2020.105091" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.+Res.&amp;title=Investigation+of+cancer+drug+resistance+mechanisms+by+phosphoproteomics&amp;author=J.C.+Boulos&amp;author=M.R.Y.+Idres&amp;author=T.+Efferth&amp;volume=160&amp;publication_year=2020&amp;pages=105091&amp;pmid=32712320&amp;doi=10.1016/j.phrs.2020.105091&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B56-cancers-15-04136">56. <span class="element-citation">Efferth T., Konkimalla V.B., Wang Y.-F., Sauerbrey A., Meinhardt S., Zintl F., Mattern J.R., Volm M. Prediction of broad spectrum resistance of tumors towards anticancer drugs. <span><span class="ref-journal">Clin. Cancer Res. </span>2008;<span class="ref-vol">14</span>:2405–2412. doi: 10.1158/1078-0432.CCR-07-4525.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18413831" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1078-0432.CCR-07-4525" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Cancer+Res.&amp;title=Prediction+of+broad+spectrum+resistance+of+tumors+towards+anticancer+drugs&amp;author=T.+Efferth&amp;author=V.B.+Konkimalla&amp;author=Y.-F.+Wang&amp;author=A.+Sauerbrey&amp;author=S.+Meinhardt&amp;volume=14&amp;publication_year=2008&amp;pages=2405-2412&amp;pmid=18413831&amp;doi=10.1158/1078-0432.CCR-07-4525&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B57-cancers-15-04136">57. <span class="element-citation">Miller D.M., Thomas S.D., Islam A., Muench D., Sedoris K. C-myc and cancer metabolism. <span><span class="ref-journal">Clin. Cancer Res. </span>2012;<span class="ref-vol">18</span>:5546–5553. doi: 10.1158/1078-0432.CCR-12-0977.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3505847/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23071356" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1078-0432.CCR-12-0977" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Cancer+Res.&amp;title=C-myc+and+cancer+metabolism&amp;author=D.M.+Miller&amp;author=S.D.+Thomas&amp;author=A.+Islam&amp;author=D.+Muench&amp;author=K.+Sedoris&amp;volume=18&amp;publication_year=2012&amp;pages=5546-5553&amp;pmid=23071356&amp;doi=10.1158/1078-0432.CCR-12-0977&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B58-cancers-15-04136">58. <span class="element-citation">Dang C.V. C-myc target genes involved in cell growth, apoptosis, and metabolism. <span><span class="ref-journal">Mol. Cell. Biol. </span>1999;<span class="ref-vol">19</span>:1–11. doi: 10.1128/MCB.19.1.1.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC83860/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9858526" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1128%2FMCB.19.1.1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cell.+Biol.&amp;title=C-myc+target+genes+involved+in+cell+growth,+apoptosis,+and+metabolism&amp;author=C.V.+Dang&amp;volume=19&amp;publication_year=1999&amp;pages=1-11&amp;pmid=9858526&amp;doi=10.1128/MCB.19.1.1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B59-cancers-15-04136">59. <span class="element-citation">Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R.C., Croce C.M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in burkitt lymphoma cells. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>1982;<span class="ref-vol">79</span>:7824–7827. doi: 10.1073/pnas.79.24.7824.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC347441/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6961453" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.79.24.7824" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=Human+c-myc+onc+gene+is+located+on+the+region+of+chromosome+8+that+is+translocated+in+burkitt+lymphoma+cells&amp;author=R.+Dalla-Favera&amp;author=M.+Bregni&amp;author=J.+Erikson&amp;author=D.+Patterson&amp;author=R.C.+Gallo&amp;volume=79&amp;publication_year=1982&amp;pages=7824-7827&amp;pmid=6961453&amp;doi=10.1073/pnas.79.24.7824&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B60-cancers-15-04136">60. <span class="element-citation">Vennstrom B., Sheiness D., Zabielski J., Bishop J.M. Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. <span><span class="ref-journal">J. Virol. </span>1982;<span class="ref-vol">42</span>:773–779. doi: 10.1128/jvi.42.3.773-779.1982.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC256910/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6284994" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1128%2Fjvi.42.3.773-779.1982" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=Isolation+and+characterization+of+c-myc,+a+cellular+homolog+of+the+oncogene+(v-myc)+of+avian+myelocytomatosis+virus+strain+29&amp;author=B.+Vennstrom&amp;author=D.+Sheiness&amp;author=J.+Zabielski&amp;author=J.M.+Bishop&amp;volume=42&amp;publication_year=1982&amp;pages=773-779&amp;pmid=6284994&amp;doi=10.1128/jvi.42.3.773-779.1982&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B61-cancers-15-04136">61. <span class="element-citation">Duffy M.J., O&#x02019;Grady S., Tang M., Crown J. Myc as a target for cancer treatment. <span><span class="ref-journal">Cancer Treat. Rev. </span>2021;<span class="ref-vol">94</span>:102154. doi: 10.1016/j.ctrv.2021.102154.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33524794" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ctrv.2021.102154" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Treat.+Rev.&amp;title=Myc+as+a+target+for+cancer+treatment&amp;author=M.J.+Duffy&amp;author=S.+O&#x02019;Grady&amp;author=M.+Tang&amp;author=J.+Crown&amp;volume=94&amp;publication_year=2021&amp;pages=102154&amp;pmid=33524794&amp;doi=10.1016/j.ctrv.2021.102154&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B62-cancers-15-04136">62. <span class="element-citation">Whitfield J.R., Soucek L. The long journey to bring a myc inhibitor to the clinic. <span><span class="ref-journal">J. Cell Biol. </span>2021;<span class="ref-vol">220</span>:e202103090. doi: 10.1083/jcb.202103090.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8240852/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34160558" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1083%2Fjcb.202103090" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Cell+Biol.&amp;title=The+long+journey+to+bring+a+myc+inhibitor+to+the+clinic&amp;author=J.R.+Whitfield&amp;author=L.+Soucek&amp;volume=220&amp;publication_year=2021&amp;pages=e202103090&amp;pmid=34160558&amp;doi=10.1083/jcb.202103090&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B63-cancers-15-04136">63. <span class="element-citation">Jovanovi&#x00107; K.K., Roche-Lestienne C., Ghobrial I.M., Facon T., Quesnel B., Manier S. Targeting myc in multiple myeloma. <span><span class="ref-journal">Leukemia. </span>2018;<span class="ref-vol">32</span>:1295–1306. doi: 10.1038/s41375-018-0036-x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29467490" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41375-018-0036-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Targeting+myc+in+multiple+myeloma&amp;author=K.K.+Jovanovi&#x00107;&amp;author=C.+Roche-Lestienne&amp;author=I.M.+Ghobrial&amp;author=T.+Facon&amp;author=B.+Quesnel&amp;volume=32&amp;publication_year=2018&amp;pages=1295-1306&amp;pmid=29467490&amp;doi=10.1038/s41375-018-0036-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B64-cancers-15-04136">64. <span class="element-citation">Bretones G., Delgado M.D., Le&#x000f3;n J. Myc and cell cycle control. <span><span class="ref-journal">Biochim. Biophys. Acta (BBA)-Gene Regul. Mech. </span>2015;<span class="ref-vol">1849</span>:506–516. doi: 10.1016/j.bbagrm.2014.03.013.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24704206" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bbagrm.2014.03.013" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.+Biophys.+Acta+(BBA)-Gene+Regul.+Mech.&amp;title=Myc+and+cell+cycle+control&amp;author=G.+Bretones&amp;author=M.D.+Delgado&amp;author=J.+Le&#x000f3;n&amp;volume=1849&amp;publication_year=2015&amp;pages=506-516&amp;pmid=24704206&amp;doi=10.1016/j.bbagrm.2014.03.013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B65-cancers-15-04136">65. <span class="element-citation">Boichuk S., Galembikova A., Zykova S., Ramazanov B., Khusnutdinov R., Dunaev P., Khaibullina S., Lombardi V. Ethyl-2-amino-pyrrole-3-carboxylates are novel potent anticancer agents that affect tubulin polymerization, induce g2/m cell-cycle arrest, and effectively inhibit soft tissue cancer cell growth in vitro. <span><span class="ref-journal">Anti-Cancer Drugs. </span>2016;<span class="ref-vol">27</span>:620–634. doi: 10.1097/CAD.0000000000000372.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27129079" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2FCAD.0000000000000372" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anti-Cancer+Drugs&amp;title=Ethyl-2-amino-pyrrole-3-carboxylates+are+novel+potent+anticancer+agents+that+affect+tubulin+polymerization,+induce+g2/m+cell-cycle+arrest,+and+effectively+inhibit+soft+tissue+cancer+cell+growth+in+vitro&amp;author=S.+Boichuk&amp;author=A.+Galembikova&amp;author=S.+Zykova&amp;author=B.+Ramazanov&amp;author=R.+Khusnutdinov&amp;volume=27&amp;publication_year=2016&amp;pages=620-634&amp;pmid=27129079&amp;doi=10.1097/CAD.0000000000000372&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B66-cancers-15-04136">66. <span class="element-citation">Mc Gee M.M. Targeting the mitotic catastrophe signaling pathway in cancer. <span><span class="ref-journal">Mediat. Inflamm. </span>2015;<span class="ref-vol">2015</span>:146282. doi: 10.1155/2015/146282.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4600505/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26491220" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1155%2F2015%2F146282" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mediat.+Inflamm.&amp;title=Targeting+the+mitotic+catastrophe+signaling+pathway+in+cancer&amp;author=M.M.+Mc+Gee&amp;volume=2015&amp;publication_year=2015&amp;pages=146282&amp;doi=10.1155/2015/146282&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B67-cancers-15-04136">67. <span class="element-citation">Alexandrova N., Niklinski J., Bliskovsky V., Otterson G.A., Blake M., Kaye F.J., Zajac-Kaye M. The n-terminal domain of c-myc associates with alpha-tubulin and microtubules in vivo and in vitro. <span><span class="ref-journal">Mol. Cell. Biol. </span>1995;<span class="ref-vol">15</span>:5188–5195. doi: 10.1128/MCB.15.9.5188.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC230766/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7651436" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1128%2FMCB.15.9.5188" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cell.+Biol.&amp;title=The+n-terminal+domain+of+c-myc+associates+with+alpha-tubulin+and+microtubules+in+vivo+and+in+vitro&amp;author=N.+Alexandrova&amp;author=J.+Niklinski&amp;author=V.+Bliskovsky&amp;author=G.A.+Otterson&amp;author=M.+Blake&amp;volume=15&amp;publication_year=1995&amp;pages=5188-5195&amp;pmid=7651436&amp;doi=10.1128/MCB.15.9.5188&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B68-cancers-15-04136">68. <span class="element-citation">Bressin C., Bourgarel-Rey V., Carr&#x000e9; M., Pourroy B., Arango D., Braguer D., Barra Y. Decrease in c-myc activity enhances cancer cell sensitivity to vinblastine. <span><span class="ref-journal">Anti-Cancer Drugs. </span>2006;<span class="ref-vol">17</span>:181–187. doi: 10.1097/00001813-200602000-00009.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16428936" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2F00001813-200602000-00009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anti-Cancer+Drugs&amp;title=Decrease+in+c-myc+activity+enhances+cancer+cell+sensitivity+to+vinblastine&amp;author=C.+Bressin&amp;author=V.+Bourgarel-Rey&amp;author=M.+Carr&#x000e9;&amp;author=B.+Pourroy&amp;author=D.+Arango&amp;volume=17&amp;publication_year=2006&amp;pages=181-187&amp;pmid=16428936&amp;doi=10.1097/00001813-200602000-00009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B69-cancers-15-04136">69. <span class="element-citation">Agut R., Falomir E., Murga J., Mart&#x000ed;n-Beltr&#x000e1;n C., Gil-Edo R., Pla A., Carda M., D&#x000ed;az J.F., Josa-Prado F., Marco J.A. Synthesis of n-acyl derivatives of aminocombretastatin a-4 and study of their interaction with tubulin and downregulation of c-myc. <span><span class="ref-journal">Med. Chem. </span>2021;<span class="ref-vol">17</span>:1129–1139. doi: 10.2174/1573406416666201120103913.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33222678" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2174%2F1573406416666201120103913" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med.+Chem.&amp;title=Synthesis+of+n-acyl+derivatives+of+aminocombretastatin+a-4+and+study+of+their+interaction+with+tubulin+and+downregulation+of+c-myc&amp;author=R.+Agut&amp;author=E.+Falomir&amp;author=J.+Murga&amp;author=C.+Mart&#x000ed;n-Beltr&#x000e1;n&amp;author=R.+Gil-Edo&amp;volume=17&amp;publication_year=2021&amp;pages=1129-1139&amp;pmid=33222678&amp;doi=10.2174/1573406416666201120103913&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B70-cancers-15-04136">70. <span class="element-citation">Jiang M.-R., Li Y.-C., Yang Y., Wu J.-R. C-myc degradation induced by DNA damage results in apoptosis of cho cells. <span><span class="ref-journal">Oncogene. </span>2003;<span class="ref-vol">22</span>:3252–3259. doi: 10.1038/sj.onc.1206501.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12761495" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1206501" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=C-myc+degradation+induced+by+DNA+damage+results+in+apoptosis+of+cho+cells&amp;author=M.-R.+Jiang&amp;author=Y.-C.+Li&amp;author=Y.+Yang&amp;author=J.-R.+Wu&amp;volume=22&amp;publication_year=2003&amp;pages=3252-3259&amp;pmid=12761495&amp;doi=10.1038/sj.onc.1206501&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B71-cancers-15-04136">71. <span class="element-citation">Popov N., Herold S., Llamazares M., Sch&#x000fc;lein C., Eilers M. Fbw7 and usp28 regulate myc protein stability in response to DNA damage. <span><span class="ref-journal">Cell Cycle. </span>2007;<span class="ref-vol">6</span>:2327–2331. doi: 10.4161/cc.6.19.4804.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17873522" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4161%2Fcc.6.19.4804" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;title=Fbw7+and+usp28+regulate+myc+protein+stability+in+response+to+DNA+damage&amp;author=N.+Popov&amp;author=S.+Herold&amp;author=M.+Llamazares&amp;author=C.+Sch&#x000fc;lein&amp;author=M.+Eilers&amp;volume=6&amp;publication_year=2007&amp;pages=2327-2331&amp;pmid=17873522&amp;doi=10.4161/cc.6.19.4804&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B72-cancers-15-04136">72. <span class="element-citation">Watson N.C., Di Y.M., Orr M.S., Fornari J.K., Jr., Randolph K.J., Magnet P.T.J., Gewirtz D.A. Influence of ionizing radiation on proliferation, c-myc expression and the induction of apoptotic cell death in two breast tumour cell lines differing in p53 status. <span><span class="ref-journal">Int. J. Radiat. Biol. </span>1997;<span class="ref-vol">72</span>:547–559.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9374435" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Radiat.+Biol.&amp;title=Influence+of+ionizing+radiation+on+proliferation,+c-myc+expression+and+the+induction+of+apoptotic+cell+death+in+two+breast+tumour+cell+lines+differing+in+p53+status&amp;author=N.C.+Watson&amp;author=Y.M.+Di&amp;author=M.S.+Orr&amp;author=J.K.+Fornari&amp;author=K.J.+Randolph&amp;volume=72&amp;publication_year=1997&amp;pages=547-559&amp;pmid=9374435&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B73-cancers-15-04136">73. <span class="element-citation">Lu H.-R., Meng L.-H., Huang M., Zhu H., Miao Z.-H., Ding J. DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase ii inhibitor, salvicine, in human breast cancer mcf-7 cells. <span><span class="ref-journal">Cancer Chemother. Pharmacol. </span>2005;<span class="ref-vol">55</span>:286–294. doi: 10.1007/s00280-004-0877-z.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15592835" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00280-004-0877-z" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Chemother.+Pharmacol.&amp;title=DNA+damage,+c-myc+suppression+and+apoptosis+induced+by+the+novel+topoisomerase+ii+inhibitor,+salvicine,+in+human+breast+cancer+mcf-7+cells&amp;author=H.-R.+Lu&amp;author=L.-H.+Meng&amp;author=M.+Huang&amp;author=H.+Zhu&amp;author=Z.-H.+Miao&amp;volume=55&amp;publication_year=2005&amp;pages=286-294&amp;pmid=15592835&amp;doi=10.1007/s00280-004-0877-z&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B74-cancers-15-04136">74. <span class="element-citation">Cui F., Fan R., Chen Q., He Y., Song M., Shang Z., Zhang S., Zhu W., Cao J., Guan H. The involvement of c-myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of atm and DNA-pkcs activity. <span><span class="ref-journal">Mol. Cell. Biochem. </span>2015;<span class="ref-vol">406</span>:43–51. doi: 10.1007/s11010-015-2422-2.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26049366" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs11010-015-2422-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cell.+Biochem.&amp;title=The+involvement+of+c-myc+in+the+DNA+double-strand+break+repair+via+regulating+radiation-induced+phosphorylation+of+atm+and+DNA-pkcs+activity&amp;author=F.+Cui&amp;author=R.+Fan&amp;author=Q.+Chen&amp;author=Y.+He&amp;author=M.+Song&amp;volume=406&amp;publication_year=2015&amp;pages=43-51&amp;pmid=26049366&amp;doi=10.1007/s11010-015-2422-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B75-cancers-15-04136">75. <span class="element-citation">Ahmadi S.E., Rahimi S., Zarandi B., Chegeni R., Safa M. Myc: A multipurpose oncogene with prognostic and therapeutic implications in blood malignancies. <span><span class="ref-journal">J. Hematol. Oncol. </span>2021;<span class="ref-vol">14</span>:121. doi: 10.1186/s13045-021-01111-4.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8351444/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34372899" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs13045-021-01111-4" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Hematol.+Oncol.&amp;title=Myc:+A+multipurpose+oncogene+with+prognostic+and+therapeutic+implications+in+blood+malignancies&amp;author=S.E.+Ahmadi&amp;author=S.+Rahimi&amp;author=B.+Zarandi&amp;author=R.+Chegeni&amp;author=M.+Safa&amp;volume=14&amp;publication_year=2021&amp;pages=121&amp;pmid=34372899&amp;doi=10.1186/s13045-021-01111-4&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B76-cancers-15-04136">76. <span class="element-citation">Siu K.T., Ramachandran J., Yee A.J., Eda H., Santo L., Panaroni C., Mertz J.A., Sims Iii R.J., Cooper M.R., Raje N. Preclinical activity of cpi-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma. <span><span class="ref-journal">Leukemia. </span>2017;<span class="ref-vol">31</span>:1760–1769. doi: 10.1038/leu.2016.355.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27890933" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fleu.2016.355" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Preclinical+activity+of+cpi-0610,+a+novel+small-molecule+bromodomain+and+extra-terminal+protein+inhibitor+in+the+therapy+of+multiple+myeloma&amp;author=K.T.+Siu&amp;author=J.+Ramachandran&amp;author=A.J.+Yee&amp;author=H.+Eda&amp;author=L.+Santo&amp;volume=31&amp;publication_year=2017&amp;pages=1760-1769&amp;pmid=27890933&amp;doi=10.1038/leu.2016.355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B77-cancers-15-04136">77. <span class="element-citation">Ghosalkar J., Iyer S., Malhotra G., Joshi K. In vitro and in vivo anticancer potential of adapalene, a third-generation retinoid against bladder cancer. <span><span class="ref-journal">Cancer Res. </span>2018;<span class="ref-vol">78</span>:2316. doi: 10.1158/1538-7445.AM2018-2316.</span> [<a href="//doi.org/10.1158%2F1538-7445.AM2018-2316" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=In+vitro+and+in+vivo+anticancer+potential+of+adapalene,+a+third-generation+retinoid+against+bladder+cancer&amp;author=J.+Ghosalkar&amp;author=S.+Iyer&amp;author=G.+Malhotra&amp;author=K.+Joshi&amp;volume=78&amp;publication_year=2018&amp;pages=2316&amp;doi=10.1158/1538-7445.AM2018-2316&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B78-cancers-15-04136">78. <span class="element-citation">Ocker M., Herold C., Ganslmayer M., Hahn E.G., Schuppan D. The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro. <span><span class="ref-journal">Int. J. Cancer. </span>2003;<span class="ref-vol">107</span>:453–459. doi: 10.1002/ijc.11410.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14506747" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fijc.11410" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Cancer&amp;title=The+synthetic+retinoid+adapalene+inhibits+proliferation+and+induces+apoptosis+in+colorectal+cancer+cells+in+vitro&amp;author=M.+Ocker&amp;author=C.+Herold&amp;author=M.+Ganslmayer&amp;author=E.G.+Hahn&amp;author=D.+Schuppan&amp;volume=107&amp;publication_year=2003&amp;pages=453-459&amp;pmid=14506747&amp;doi=10.1002/ijc.11410&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B79-cancers-15-04136">79. <span class="element-citation">Patergnani S., Missiroli S., Morciano G., Perrone M., Mantovani C.M., Anania G., Fiorica F., Pinton P., Giorgi C. Understanding the role of autophagy in cancer formation and progression is a real opportunity to treat and cure human cancers. <span><span class="ref-journal">Cancers. </span>2021;<span class="ref-vol">13</span>:5622.  doi: 10.3390/cancers13225622.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8616104/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34830777" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fcancers13225622" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Understanding+the+role+of+autophagy+in+cancer+formation+and+progression+is+a+real+opportunity+to+treat+and+cure+human+cancers&amp;author=S.+Patergnani&amp;author=S.+Missiroli&amp;author=G.+Morciano&amp;author=M.+Perrone&amp;author=C.M.+Mantovani&amp;volume=13&amp;publication_year=2021&amp;pages=5622&amp;pmid=34830777&amp;doi=10.3390/cancers13225622&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B80-cancers-15-04136">80. <span class="element-citation">Jiang Z.-F., Shao L.-J., Wang W.-M., Yan X.-B., Liu R.-Y. Decreased expression of beclin-1 and lc3 in human lung cancer. <span><span class="ref-journal">Mol. Biol. Rep. </span>2012;<span class="ref-vol">39</span>:259–267. doi: 10.1007/s11033-011-0734-1.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21556768" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs11033-011-0734-1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Biol.+Rep.&amp;title=Decreased+expression+of+beclin-1+and+lc3+in+human+lung+cancer&amp;author=Z.-F.+Jiang&amp;author=L.-J.+Shao&amp;author=W.-M.+Wang&amp;author=X.-B.+Yan&amp;author=R.-Y.+Liu&amp;volume=39&amp;publication_year=2012&amp;pages=259-267&amp;pmid=21556768&amp;doi=10.1007/s11033-011-0734-1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B81-cancers-15-04136">81. <span class="element-citation">Hwang S.-K., Jeong Y.-J., Shin J.-M., Magae J., Kim C.-H., Chang Y.-C. Mac inhibits c-myc and induces autophagy by downregulation of cip2a in leukemia cells. <span><span class="ref-journal">Mol. Cell. Toxicol. </span>2018;<span class="ref-vol">14</span>:417–424. doi: 10.1007/s13273-018-0046-9.</span> [<a href="//doi.org/10.1007%2Fs13273-018-0046-9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cell.+Toxicol.&amp;title=Mac+inhibits+c-myc+and+induces+autophagy+by+downregulation+of+cip2a+in+leukemia+cells&amp;author=S.-K.+Hwang&amp;author=Y.-J.+Jeong&amp;author=J.-M.+Shin&amp;author=J.+Magae&amp;author=C.-H.+Kim&amp;volume=14&amp;publication_year=2018&amp;pages=417-424&amp;doi=10.1007/s13273-018-0046-9&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B82-cancers-15-04136">82. <span class="element-citation">Li H., Liu J., Cao W., Xiao X., Liang L., Liu-Smith F., Wang W., Liu H., Zhou P., Ouyang R. C-myc/mir-150/epg5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer. <span><span class="ref-journal">Theranostics. </span>2019;<span class="ref-vol">9</span>:5134. doi: 10.7150/thno.34887.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6691579/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31410206" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.7150%2Fthno.34887" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=C-myc/mir-150/epg5+axis+mediated+dysfunction+of+autophagy+promotes+development+of+non-small+cell+lung+cancer&amp;author=H.+Li&amp;author=J.+Liu&amp;author=W.+Cao&amp;author=X.+Xiao&amp;author=L.+Liang&amp;volume=9&amp;publication_year=2019&amp;pages=5134&amp;pmid=31410206&amp;doi=10.7150/thno.34887&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B83-cancers-15-04136">83. <span class="element-citation">Fan Y.-J., Zong W.-X. The cellular decision between apoptosis and autophagy. <span><span class="ref-journal">Chin. J. Cancer. </span>2013;<span class="ref-vol">32</span>:121.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3845594/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23114086" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chin.+J.+Cancer&amp;title=The+cellular+decision+between+apoptosis+and+autophagy&amp;author=Y.-J.+Fan&amp;author=W.-X.+Zong&amp;volume=32&amp;publication_year=2013&amp;pages=121&amp;pmid=23114086&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B84-cancers-15-04136">84. <span class="element-citation">Kang R., Zeh H.J., Lotze M.T., Tang D. The beclin 1 network regulates autophagy and apoptosis. <span><span class="ref-journal">Cell Death Differ. </span>2011;<span class="ref-vol">18</span>:571–580. doi: 10.1038/cdd.2010.191.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3131912/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21311563" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fcdd.2010.191" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Differ.&amp;title=The+beclin+1+network+regulates+autophagy+and+apoptosis&amp;author=R.+Kang&amp;author=H.J.+Zeh&amp;author=M.T.+Lotze&amp;author=D.+Tang&amp;volume=18&amp;publication_year=2011&amp;pages=571-580&amp;pmid=21311563&amp;doi=10.1038/cdd.2010.191&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B85-cancers-15-04136">85. <span class="element-citation">Konantz M., Balci T.B., Hartwig U.F., Dellaire G., Andr&#x000e9; M.C., Berman J.N., Lengerke C. Zebrafish xenografts as a tool for in vivo studies on human cancer. <span><span class="ref-journal">Ann. N. Y. Acad. Sci. </span>2012;<span class="ref-vol">1266</span>:124–137. doi: 10.1111/j.1749-6632.2012.06575.x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22901264" ref="reftype=pubmed&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1749-6632.2012.06575.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann.+N.+Y.+Acad.+Sci.&amp;title=Zebrafish+xenografts+as+a+tool+for+in+vivo+studies+on+human+cancer&amp;author=M.+Konantz&amp;author=T.B.+Balci&amp;author=U.F.+Hartwig&amp;author=G.+Dellaire&amp;author=M.C.+Andr&#x000e9;&amp;volume=1266&amp;publication_year=2012&amp;pages=124-137&amp;pmid=22901264&amp;doi=10.1111/j.1749-6632.2012.06575.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10452460&amp;issue-id=444001&amp;journal-id=2105&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Cancers</span> are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10452460/pdf/cancers-15-04136.pdf" class="int-view">PDF (5.2M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10452460/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10452460/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10452460" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10452460%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="ROHc3cuMhVHLBEpNtgPDB2lqFESaVTGoZnVQ2qyhxlHT1FiXvzaLoLbPowIOuc3c">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10452460%2F&amp;text=In%20Silico%2C%20In%20Vitro%2C%20and%20In%20Vivo%20Investigations%20on%20Adapalene%20as%20Repurposed%20Third%20Generation%20Retinoid%20against%20Multiple%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10452460%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452460/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10452460/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37627164/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10452460/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37627164/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10452460/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10452460/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10452460/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
